<?xml version="1.0" encoding="utf-8" ?>

<XML>
  <JOURNAL>   
    <YEAR>2025</YEAR>
    <VOL>26</VOL>
    <NO>2</NO>
    <MOSALSAL>103</MOSALSAL>
    <PAGE_NO>73</PAGE_NO>  
    <ARTICLES>

<ARTICLE>
    <TitleF></TitleF>
    <TitleE>Are IVF Clinics Ready to Deal with Any Potential Crisis or Disaster?</TitleE>
    <TitleLang_ID>2</TitleLang_ID>
    <ABSTRACTS>
        <ABSTRACT>
            <Language_ID>1</Language_ID>
            <CONTENT>140271</CONTENT>
        </ABSTRACT>
        <ABSTRACT>
            <Language_ID>2</Language_ID>
            <CONTENT>&lt;p&gt;In the quality management programs of healthcare systems and hospitals, there is a special focus on emergency preparedness and risk management as a requirement in preventive action plans. IVF clinics are at the forefront of this attention. The vulnerability of IVF clinics to various threats, including regional wars and conflicts, natural disasters and crisis, power outages and cyberattacks, is greater compared to other healthcare facilities. In addition to &#160;planning for protection of patients and staff in IVF clinics, special considerations and measures are necessary due to elevated vulnerability of stored biological materials and the irreparable loss of gametes, embryos, and reproductive tissues. The loss or threat to stored biological materials in IVF clinics has significant legal and emotional consequences for the patients, service providers, and the healthcare system (1).&#160;&lt;br /&gt;
IVF clinics should implement a range of comprehensive strategies, to ensure the safety of staff and patients as well as the continuity and security of reproductive materials in emergencies, through delineating funda-mental principles of accreditation, quality management, and experiences from past incidents and disasters. Accreditation and quality management systems (QMS) play a key role in emergency preparedness. IVF clinics are always advised to operate with the core principles of accreditation, even if they are not formally accredited. Formal accreditation as a requirement provides a framework and principle of proactive planning to withstand disruptions and protect critical reproductive care services. A robust QMS, as a quality framework, is essential to govern all operational practices and manage potential risks. Professional societies such as ASRM, ESHRE, SAR, and SRBT emphasize that such systems must address: ensuring the safety and protection of staff and patients; maintaining the safety and viability of fresh and frozen biological materials such as embryos, oocytes, sperm, and tissues; protecting and securing critical data including patient and laboratory records, financial documents, and equipment; and finally establishing clear guidelines for continuing or discontinuing patient treatment. All these plans require &quot;all-hazards&quot; risk assessment encompassing pandemics, natural disasters (&lt;em&gt;e.g&lt;/em&gt;., fires, floods, earthquakes, hurricanes, and blizzards), power outages, terrorist attacks, cyberattacks, and equipment failures (1-3).&#160;&lt;br /&gt;
IVF clinics are recommended to establish procedures to monitor adequate liquid nitrogen (LN2) levels and temperatures in all critical storage containers. This includes checking dewars at least three times a week or using continuous electronic monitoring systems with 24-&lt;em&gt;hr&lt;/em&gt; remote alarms that immediately notify personnel if critical values are reached. For faster response to vacuum failures, LN2-immersed level probes are preferred over vapor-immersed temperature probes. An adequate supply of LN2 should be maintained on site, possibly including double ordering in anticipation of shipping delays. LN2 availability must be evaluated by risk assessment programs, which may be achieved through agreements with other facilities to share the costs of an LN2 generator. It is preferable to visually inspect the tanks for damage such as sweating, cracking, or rust, and any tank losing LN2 faster than expected should have its contents transferred to a spare tank and replaced. It is beneficial that the new storage tanks undergo a rigorous 30-day performance validation process, including thermal imaging, dual probe temperature checks, and weight monitoring, before being put into active use. Access to cryo-storage tanks and the LN2 source should be limited to authorized and trained personnel. Furthermore, tanks are advised to be located in well-ventilated areas, and oxygen monitors with audible and visual alarms are essential to detect hypoxic environments caused by LN2 release. Moving LN2 tanks to a safer location is recommended if there is adequate warning of an impending emergency. These new locations need to be secured and marked so that non-medical personnel (&lt;em&gt;e.g&lt;/em&gt;., fire, police) can easily identify them, and the relevant authorities are notified in advance. In fact, moving large tanks is more difficult and requires careful planning (1, 4, 5).&lt;br /&gt;
In crises and disasters, operations should be hibernated, new cycled halted, and all gametes and embryos immediately frozen until the implementation of safe strategies. Emergency freezing of day zero to day five (D0-D5) oocytes and embryos is a safe and effective protective measure during disasters. For example, during the Zhengzhou flood in 2021, 1,246 oocytes and embryos from 155 patients were successfully frozen with only emergency power supplies. Similarly, during the 2025 Iran-Israel twelve-day war, oocytes and embryos were frozen at all IVF clinics in war-involved areas. In some cases, embryologists may strategically freeze and store D0/D1 embryos to reduce the potential risks of freezing (4).&#160;&lt;br /&gt;
Duplicate records for recognizing sample ownership should be maintained in a secure location separate from the primary storage site, ideally off-site or on a secure web server for proper data management and security. In the event of power outage or cyberattack, paper documents become critical for patient and embryology records. Printing electronic documents in preparation for anticipated disasters is a good strategy. Healthcare organizations are vulnerable to cyber threats, so emergency plans must include protocols for complete computer shutdown, with a focus on recovering electronic medical record (EMR), laboratory systems, and imaging archive modules that are critical for resuming normal clinical practice. Moreover, staff training in manual documentation and procedures is essential. Recruiting adequate staff for all clinic procedures and emergency response who receive emergency preparedness training commensurate with their job responsibi-lities is a great step in emergency plans. Announced and unannounced maneuvers should be conducted per-iodically to educate staff on safety features, evacuation plans, and to test their ability to execute the emergency action plan. In addition, clear and prompt communication from management is critical to support staff (1, 3).&lt;br /&gt;
A proper policy to diminish the risks of power outages in disasters, incorporating UPS systems for providing 6–8 &lt;em&gt;hr&lt;/em&gt; of &#160;full-load operation, and on-site generator fuel for at least 3–4 days of continuous operation represent optimal practices in IVF clinics. Ensuring a suitable and uninterrupted power supply of incubator gases, including pre-mixed gas compositions, is critical to maintain ideal culture conditions. Adequate stocks of consumables (&lt;em&gt;e.g.&lt;/em&gt;, 3 months of supply) should be maintained and substitute and pre-evaluated suppliers be identified to minimize supply chain disruptions. It is suggested to properly secure equipment against potential damage and to ensure alarm systems notify personnel of their malfunction or adverse environmental con-ditions. Re-validation of equipment after a period of non-use in emergencies is also essential (1, 4).&lt;br /&gt;
IVF clinics are encouraged to establish formal &quot;mutual support agreements&quot; with one or more nearby clinics to ensure continuity of care during crises. A growing number of centers are relying on off-site commercial storage facilities for long-term storage of frozen samples. These facilities are specifically designed to protect samples from disasters and provide climate-controlled environments, 24-&lt;em&gt;hr&lt;/em&gt; monitoring, and strong security. Professional cryogenic shipping services are necessary for safe handling of biological specimens. Patients should be promptly informed via consent forms about the location and status of their stored samples, that they may be transferred to other centers in the event of an emergency, and that any compromise or destruction of tissue will be reported and documented (2, 3, 5).&#160;&lt;br /&gt;
All in all, IVF clinics need to learn from the past. The COVID-19 pandemic highlighted vulnerabilities in the supply chains of personal protective equipment (PPE), consumables and LN2, as well as staff shortages and travel restrictions. This culminated in widespread interruptions of elective treatments globally and increased reliance on telemedicine for consultations. In another case, the NYU Langone Fertility Center in the United States experienced a power outage and its backup generator failed. However, the use of UPS units was crucial for the emergency preparation and freezing of 90 embryos, resulting in 11 live births. The center also relied heavily on its local network of IVF clinics to manage patients for oocyte retrieval, resulting in 10 live births. During Hurricane Katrina, severe flooding restricted access to frozen embryos to boat transport only, making re-entry into the city impossible for extended periods and causing the loss of embryos in incubation. All disposables had to be discarded before IVF services could be resumed. The war in Ukraine severely impacted IVF clinics, causing infrastructure disruptions (e.g., power outages and clinic damage), endangering biological samples, and creating physical and logistical challenges for maintaining operations amid blackouts and airstrikes. A documented case involves Dr. Anna Sokalska, a faculty member of Stanford University, who coordinated the transport of oocytes and embryos from Kyiv to a clinic in Poland in March 2022, and per-formed extraordinary efforts to protect vital reproductive material and continue services despite the enormous difficulties caused by the war (1, 2, 4, 6).&lt;br /&gt;
In conclusion, the continuity and protection of reproductive materials in IVF clinics mainly rely on careful planning, adherence to accreditation principles, continuous monitoring of critical systems, robust data management, staff training and practice, and the establishment of mutual support networks and off-site storage solutions. Learning from past emergencies will continually refine these strategies and prepare facilities for the unpredictable challenges of the future.&lt;/p&gt;</CONTENT>
        </ABSTRACT>
    </ABSTRACTS>
    <PAGES>
        <PAGE>
            <FPAGE>069</FPAGE>
            <TPAGE>72</TPAGE>
        </PAGE>
    </PAGES>
    <AUTHORS>
        <AUTHOR>
<Name>Mohammad Reza</Name>
<MidName>MR</MidName>
<Family>Sadeghi</Family>
<NameE> محمدرضا</NameE>
<MidNameE></MidNameE>
<FamilyE>صادقی</FamilyE>
<Organizations>
<Organization>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR</Organization>
</Organizations>
<Universities>
<University>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email>sadeghi@avicenna.ac.ir</Email>
</EMAILS>
</AUTHOR>
    </AUTHORS>
    <KEYWORDS>
        <KEYWORD><KeyText>No Keyword</KeyText></KEYWORD>
    </KEYWORDS>
    <PDFFileName>140271.pdf</PDFFileName>
    <REFRENCES>
        <REFRENCE>
            <REF>Cairo consensus group 2023, alpha scientists in reproductive medicine. Cairo consensus on accreditation as the basis for future-proofing the ART laboratory. Reprod Biomed Online. 2025;50(1):104106.##Goldman KN, McCaffrey C, Riley J, Jungheim E, Grifo JA. Disaster preparedness in assisted reproductive technology. Fertil Steril. 2022;118(2):230-8.##Practice committees of the American society for reproductive medicine, the society for assisted reproductive technology, and the society of reproductive biologists and technologists. Electronic. Development of an emergency plan for in vitro fertilization programs: a committee opinion. Fertil Steril. 2021;115(4):870-3.##Song W, Zhang F, Wang Y, Shi H, Sun N, Jin H, et al. Effective protection: the embryonic development and clinical outcomes of emergency vitrification of 1246 oocytes and day 0-day 5 embryos in a natural disaster. Hum Reprod. 2023;38(12):2412-21.##Practice committees of the American society for reproductive medicine, society for reproductive biologists and technologists, and society for assisted reproductive technology. Cryostorage of reproductive tissues in the in vitro fertilization laboratory: a committee opinion. Fertil Steril. 2020;114(3):486-91.##Stanford Medicine. Lending a helping hand to a Ukraine IVF clinic [Internet]. Stanford (CA): Stanford School of Medicine; c2025 [cited 2025 Aug 27]. Available from: https://obgyn.stanford.edu/in-the-news/lending-a-helping-hand-to-a-ukraine-ivf-clinic.html.##</REF>
        </REFRENCE>
    </REFRENCES>
</ARTICLE>

<ARTICLE>
    <TitleF></TitleF>
    <TitleE>Impact of Intrauterine Growth Restriction on Fetal Cortical Brain Development: A Neurosonographic Assessment at 28-36 Weeks of Gestation</TitleE>
    <TitleLang_ID>2</TitleLang_ID>
    <ABSTRACTS>
        <ABSTRACT>
            <Language_ID>1</Language_ID>
            <CONTENT>140262</CONTENT>
        </ABSTRACT>
        <ABSTRACT>
            <Language_ID>2</Language_ID>
            <CONTENT>&lt;p&gt;Background: Cortical folding during fetal brain development reflects neural maturation. Fetal growth restriction (FGR) may disrupt this process, potentially affecting neurodevelopmental outcomes. Although ultrasound enables noninvasive sulcal assessment, so normative data and objective tools are lacking. The purpose of the current study was to assess the impact of FGR on fetal cortical development using neurosonography and establish a third-trimester nomogram for cortical maturation.&lt;br /&gt;
Methods: This prospective study included 425 singleton pregnancies (330 appropriate-for-gestational-age [AGA], 54 symmetrical FGR, and 41 asymmetrical FGR) at 28–36 weeks. Conducted at a Tehran tertiary center (2023–2024), the study included cases with normal anatomy and negative aneuploidy screening. Neurosonographic parameters including Sylvian fissure (SF), insula, parieto-occipital fissure (POF), cavum septum pellucidum (CSP) width, and ventricular diameter were measured and the ratios calculated relative to biparietal diameter (BPD). ANOVA and post-hoc tests were applied and statistical significance was set at p&lt;0.05.&lt;br /&gt;
Results: No significant differences in neurosonographic ratios (&lt;em&gt;e.g&lt;/em&gt;., SF/Insula, POF/ BPD, CSPW/BPD) were found between AGA and FGR groups. However, unadjusted SF and insular depths were reduced in symmetrical FGR fetuses with head circumference (HC) &lt;10th percentile. Asymmetrical FGR showed no differences. A gestational-age-based nomogram was developed for AGA fetuses.&lt;br /&gt;
Conclusion: While absolute sulcal measurements vary with head size in FGR, biometric adjustments (&lt;em&gt;e.g&lt;/em&gt;., BPD ratios) improve cortical maturation assessment. The study supports ratio-based neurosonography and provides normative data for objective fetal brain evaluation.&lt;/p&gt;</CONTENT>
        </ABSTRACT>
    </ABSTRACTS>
    <PAGES>
        <PAGE>
            <FPAGE>072</FPAGE>
            <TPAGE>81</TPAGE>
        </PAGE>
    </PAGES>
    <AUTHORS>
        <AUTHOR>
<Name>Behrokh</Name>
<MidName>B</MidName>
<Family>Sahebdel</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Obstetrics and Gynecology, Fetal an  d Neonatal Research Center, Yas Hospital Complex, Tehran University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Department of Obstetrics and Gynecology, Fetal an  d Neonatal Research Center, Yas Hospital Complex, Tehran University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Reihaneh</Name>
<MidName>R</MidName>
<Family>Mortazavi Ardestani</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Radiology, Tehran University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Department of Radiology, Tehran University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Setareh</Name>
<MidName>S</MidName>
<Family>Soltani</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Clinical Research Development Center, Taleghani and Imam Ali Hospital, Kermanshah University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Clinical Research Development Center, Taleghani and Imam Ali Hospital, Kermanshah University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Mohammad Hossein</Name>
<MidName>MH</MidName>
<Family>Golezar</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Advanced Diagnostic and Interventional Radiology Research Center (ADIR), Medical Imaging Center, Tehran University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Advanced Diagnostic and Interventional Radiology Research Center (ADIR), Medical Imaging Center, Tehran University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Fatemeh</Name>
<MidName>F</MidName>
<Family>Golshahi</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Obstetrics and Gynecology, Fetal an  d Neonatal Research Center, Yas Hospital Complex, Tehran University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Department of Obstetrics and Gynecology, Fetal an  d Neonatal Research Center, Yas Hospital Complex, Tehran University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Nafiseh</Name>
<MidName>N</MidName>
<Family>Saedi</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Obstetrics and Gynecology, Fetal an  d Neonatal Research Center, Yas Hospital Complex, Tehran University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Department of Obstetrics and Gynecology, Fetal an  d Neonatal Research Center, Yas Hospital Complex, Tehran University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Fatemeh</Name>
<MidName>F</MidName>
<Family>Rahimi Sharbaf</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Obstetrics and Gynecology, Fetal an  d Neonatal Research Center, Yas Hospital Complex, Tehran University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Department of Obstetrics and Gynecology, Fetal an  d Neonatal Research Center, Yas Hospital Complex, Tehran University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Mahboobeh</Name>
<MidName>M</MidName>
<Family>Shirazi</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Obstetrics and Gynecology, Fetal an  d Neonatal Research Center, Yas Hospital Complex, Tehran University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Department of Obstetrics and Gynecology, Fetal an  d Neonatal Research Center, Yas Hospital Complex, Tehran University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Nooshin</Name>
<MidName>N</MidName>
<Family>Faraji</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Obstetrics and Gynecology, Fetal an  d Neonatal Research Center, Yas Hospital Complex, Tehran University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Department of Obstetrics and Gynecology, Fetal an  d Neonatal Research Center, Yas Hospital Complex, Tehran University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Mohadese</Name>
<MidName>M</MidName>
<Family>Dashtkoohi</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Vali-E-Asr Reproductive Health Research Center, Family Health Research Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Vali-E-Asr Reproductive Health Research Center, Family Health Research Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Zohreh</Name>
<MidName>Z</MidName>
<Family>Heidary</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Vali-E-Asr Reproductive Health Research Center, Family Health Research Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Vali-E-Asr Reproductive Health Research Center, Family Health Research Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Masoumeh</Name>
<MidName>M</MidName>
<Family>Aslanpour</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Obstetrics and Gynecology, Fetal an  d Neonatal Research Center, Yas Hospital Complex, Tehran University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Department of Obstetrics and Gynecology, Fetal an  d Neonatal Research Center, Yas Hospital Complex, Tehran University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email>dtmasiiii20@gmail.com</Email>
</EMAILS>
</AUTHOR>
    </AUTHORS>
    <KEYWORDS>
        <KEYWORD><KeyText>Cortical maturation</KeyText></KEYWORD><KEYWORD><KeyText>Fetal brain development</KeyText></KEYWORD><KEYWORD><KeyText>Fetal ultrasound</KeyText></KEYWORD><KEYWORD><KeyText>Insula</KeyText></KEYWORD><KEYWORD><KeyText>Intra-uterine growth restriction</KeyText></KEYWORD><KEYWORD><KeyText>Neurosonography</KeyText></KEYWORD><KEYWORD><KeyText>Nomogram</KeyText></KEYWORD><KEYWORD><KeyText>Sylvian fissure</KeyText></KEYWORD>
    </KEYWORDS>
    <PDFFileName>140262.pdf</PDFFileName>
    <REFRENCES>
        <REFRENCE>
            <REF>Aslan &#199;etin B, Madazlı R. Assessment of normal fetal cortical sulcus development. Arch Gynecol Obstet. 2022;306(3):735-43.##Levine D, Barnes PD. Cortical maturation in normal and abnormal fetuses as assessed with prenatal MR imaging. Radiology. 1999;210(3):751-8.##Afif A, Trouillas J, Mertens P. Development of the sensorimotor cortex in the human fetus: a morphological description. Surg Radiol Anat. 2015;37(2):153-60.##Cohen‐Sacher B, Lerman‐Sagie T, Lev D, Malinger G. Sonographic developmental milestones of the fetal cerebral cortex: a longitudinal study. Ultrasound Obstet Gynecol. 2006;27(5):494-502.##Husen SC, Koning IV, Go AT, van Graafeiland AW, Willemsen SP, Groenenberg IA, et al. Three-dimensional ultrasound imaging of fetal brain fissures in the growth restricted fetus. PLoS One. 2019;14(5):e0217538.##Alves CMS, J&#250;nior EA, Nardozza LMM, Goldman SM, Martinez LH, Martins WP, et al. Reference ranges for fetal brain fissure development on 3‐dimensional sonography in the multiplanar mode. J Ultrasound Med. 2013;32(2):269-77.##Garel C, Chantrel E, Brisse H, Elmaleh M, Luton D, Oury JF, et al. Fetal cerebral cortex: normal gestational landmarks identified using prenatal MR imaging. Am J Neuroradiol. 2001;22(1):184-9.##Snyder WE, V&#233;rtes PE, Kyriakopoulou V, Wagstyl K, Williams LZ, Moraczewski D, et al. A bimodal taxonomy of adult human brain sulcal morphology related to timing of fetal sulcation and trans-sulcal gene expression gradients. Neuron. 2024;112(20):3396-411.e6.##Zhang Z, Hou Z, Lin X, Teng G, Meng H, Zang F, et al. Development of the fetal cerebral cortex in the second trimester: assessment with 7T postmortem MR imaging. Am J Neuroradiol. 2013;34(7):1462-7.##Lubrano C, Parisi F, Cetin I. Impact of maternal environment and inflammation on fetal neurodevelopment. Antioxidants (Basel). 2024;13(4):453.##Vasistha NA, Khodosevich K. The impact of (ab)normal maternal environment on cortical development. Prog Neurobiol. 2021;202:102054.##Hertz‐Picciotto I, Korrick SA, Ladd‐Acosta C, Karagas MR, Lyall K, Schmidt RJ, et al. Maternal tobacco smoking and offspring autism spectrum disorder or traits in ECHO cohorts. Autism Res. 2022;15(3):551-69.##Vargas-Rodr&#237;guez C, Chimenea A, Anti&#241;olo G, Garc&#237;a-D&#237;az L. Insights into neurosonographic indicators for prenatal diagnosis of fetal neurological anomalies and cortical development: a systematic review of the literature. Early Hum Dev. 2024;197:106109.##Egana‐Ugrinovic G, Sanz‐Cortes M, Figueras F, Couve‐Perez C, Gratac&#243;s E. Fetal MRI insular cortical morphometry and its association with neurobehavior in late‐onset small‐for‐gestational‐age fetuses. Ultrasound Obstet Gynecol. 2014;44(3):322-9.##Paules C, Miranda J, Policiano C, Crovetto F, Youssef L, Hahner N, et al. Fetal neurosonography detects differences in cortical development and corpus callosum in late‐onset small fetuses. Ultrasound Obstet Gynecol. 2021;58(1):42-7.##Ega&#241;a-Ugrinovic G, Sanz-Cortes M, Figueras F, Bargall&#243; N, Gratac&#243;s E. Differences in cortical development assessed by fetal MRI in late-onset intrauterine growth restriction. Am J Obstet Gynecol. 2013;209(2):126.e1-e8.##Sucksdorff M, Lehtonen L, Chudal R, Suominen A, Joelsson P, Gissler M, et al. Preterm birth and poor fetal growth as risk factors of attention-deficit/hyperactivity disorder. Pediatrics. 2015;136(3):e599-608.##Businelli C, De Wit C, Visser GH, Pistorius LR. Ultrasound evaluation of cortical brain development in fetuses with intrauterine growth restriction. J Matern Fetal Neonatal Med. 2015;28(11):1302-7.##Figueras F, Cruz‐Martinez R, Sanz‐Cortes M, Arranz A, Illa M, Botet F, et al. Neurobehavioral outcomes in preterm, growth‐restricted infants with and without prenatal advanced signs of brain‐sparing. Ultrasound Obstet Gynecol. 2011;38(3):288-94.##Ega&#241;a‐Ugrinovic G, Sanz‐Cort&#233;s M, Couve‐P&#233;rez C, Figueras F, Gratac&#243;s E. Corpus callosum differences assessed by fetal MRI in late‐onset intrauterine growth restriction and its association with neurobehavior. Prenat Diagn. 2014;34(9):843-9.##Alonso I, Borenstein M, Grant G, Narbona I, Azumendi G. Depth of brain fissures in normal fetuses by prenatal ultrasound between 19 and 30 weeks of gestation. Ultrasound Obstet Gynecol. 2010;36(6):693-9.##Peng R, Yin X, Liu Y, He M, Wu HL, Xie HN. Development and validation of a predictive model for fetal cerebral maturation using ultrasound for fetuses with normal growth and fetal growth restriction. Quant Imaging Med Surg. 2023;13(12):8435-44.##Mammadova N, Bozbay N, Orgul G. Evaluation of cerebral fissure depths measured by prenatal ultrasonography in healthy fetuses at 20–24 weeks gestational age. Eur J Obstet Gynecol Reprod Biol. 2024;302:254-61.##Yun HJ, Lee HJ, Lee JY, Tarui T, Rollins CK, Ortinau CM, et al. Quantification of sulcal emergence timing and its variability in early fetal life: hemispheric asymmetry and sex difference. NeuroImage. 2022;263:119629.##Clouchoux C, Du Plessis A, Bouyssi-Kobar M, Tworetzky W, McElhinney D, Brown D, et al. Delayed cortical development in fetuses with complex congenital heart disease. Cerebral Cortex. 2013;23(12):2932-43.##Warren DJ, Connolly DJA, Griffiths PD. Assessment of sulcation of the fetal brain in cases of isolated agenesis of the corpus callosum using in utero MR imaging. Am J Neuroradiol. 2010;31(6):1085-90.##Basso A, Youssef L, Nakaki A, Paules C, Miranda J, Casu G, et al. Fetal neurosonography at 31–35 weeks reveals altered cortical development in pre‐eclampsia with and without small‐for‐gestational‐age fetus. Ultrasound Obstet Gynecol. 2022;59(6):737-46.##Putra M, Peek E, Hobbins JC. Fetal insular measurements in pregnancy with estimated fetal weight &lt;10th centile and childhood neurodevelopmental outcomes. Am J Obstet Gynecol. 2024;230(1):85.e1-85.e15.##Welling MS, Husen SC, Go AT, Groenenberg IA, Willemsen SP, Bijma HH, et al. Growth trajectories of the human fetal brain in healthy and complicated pregnancies and associations with neurodevelopmental outcome in the early life course. Early Hum Dev. 2020;151:105224.##Abe S, Takagi K, Yamamoto T, Kato T. Assessment of cortical gyrus and sulcus formation using magnetic resonance images in small‐for‐gestational‐age fetuses. Prenatal Diagn. 2004;24(5):333-8.##Oliveira REd, Teixeira SR, Santana EFM, Elias J, Costa FdS, Araujo E, et al. Magnetic resonance imaging of skull and brain parameters in fetuses with intrauterine growth restriction. Radiol Bras. 2021;54(3):141-7.##Silva PIP, Perez M. Prenatal ultrasound diagnosis of biometric changes in the brain of growth restricted fetuses. A systematic review of literature. Rev Bras Ginecol Obstet. 2021;43(07):545-59.##Clouchoux C, Kudelski D, Gholipour A, Warfield SK, Viseur S, Bouyssi-Kobar M, et al. Quantitative in vivo MRI measurement of cortical development in the fetus. Brain Struct Funct. 2012;217(1):127-39.##Ramenghi LA, Martinelli A, De Carli A, Brusati V, Mandia L, Fumagalli M, et al. Cerebral maturation in IUGR and appropriate for gestational age preterm babies. Reprod Sci. 2011;18(5):469-75.##Ben&#237;tez-Mar&#237;n MJ, Mar&#237;n-Clavijo J, Blanco-Elena JA, Jim&#233;nez-L&#243;pez J, Gonz&#225;lez-Mesa E. Brain sparing effect on neurodevelopment in children with intrauterine growth restriction: a systematic review. Children (Basel). 2021;8(9):745.##</REF>
        </REFRENCE>
    </REFRENCES>
</ARTICLE>

<ARTICLE>
    <TitleF></TitleF>
    <TitleE>The Effect of Letrozole and N-Acetylcysteine on the Expression Levels of Genes Involved in Glucose Metabolism in Patients with Polycystic Ovary Syndrome: A Clinical Trial Study</TitleE>
    <TitleLang_ID>2</TitleLang_ID>
    <ABSTRACTS>
        <ABSTRACT>
            <Language_ID>1</Language_ID>
            <CONTENT>140264</CONTENT>
        </ABSTRACT>
        <ABSTRACT>
            <Language_ID>2</Language_ID>
            <CONTENT>&lt;p&gt;Background: N-acetylcysteine (NAC) is a supplement commonly used in patients with polycystic ovary syndrome (PCOS). The expansion of oocyte-associated cumulus cells (CCs) and the quality of the oocyte are critical factors influencing fertilization rates and clinical pregnancy outcomes in assisted reproductive techniques (ARTs). Genes such as phosphofructokinase (PFKP) and pyruvate kinase isoform M2 (PKM2) are involved in glucose metabolism and are crucial in the regulation of oocyte competence and developmental potential. The purpose of the current study was to evaluate the effects of letrozole and NAC on the expression of PFKP and PKM2 in CCs of PCOS patients undergoing ART.&#160;&lt;br /&gt;
Methods: The study evaluated 20 PCOS women undergoing ART to assess the effect of letrozole and NAC on the expression levels of PKM2 and PFKP genes in cumulus cells. Women were randomly assigned using a simple randomization method into four groups: control, NAC, letrozole, and NAC plus letrozole, with five women in each group. Gene expression levels of PKM2 and PFKP were measured using real-time PCR.&lt;br /&gt;
Results: The expression level of PKM2 was significantly higher in the letrozole plus NAC group compared to the control group (p&lt;0.05). In NAC group, PFKP was significantly expressed compared to the control group (p&lt;0.05). There were no significant differences among the other groups compared to the control group.&#160;&lt;br /&gt;
Conclusion: NAC can improve the quality of oocytes by increasing the expression level of genes involved in the glucose metabolism (PKM2, PFKP) of CCs, thereby potentially improving ART success rate in PCOS patients. Therefore, administering NAC along with letrozole can have a synergistic effect on increasing the expression level of genes associated with blastocyst quality in PCOS patients.&lt;/p&gt;</CONTENT>
        </ABSTRACT>
    </ABSTRACTS>
    <PAGES>
        <PAGE>
            <FPAGE>081</FPAGE>
            <TPAGE>90</TPAGE>
        </PAGE>
    </PAGES>
    <AUTHORS>
        <AUTHOR>
<Name>Ebrahim</Name>
<MidName>E</MidName>
<Family>Jafarzadeh</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Anatomical Sciences, Faculty of Medicine, Tabriz University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Department of Anatomical Sciences, Faculty of Medicine, Tabriz University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Roghiyeh</Name>
<MidName>R</MidName>
<Family>Pashaei-Asl</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Interdisciplinary Research Development Center, Iran University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Interdisciplinary Research Development Center, Iran University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Parvin</Name>
<MidName>P</MidName>
<Family>Hakimi</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Women’s Reproductive Health Research Center, Tabriz University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Women’s Reproductive Health Research Center, Tabriz University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email>Parvin.hakimi56@gmail.com</Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Maryam</Name>
<MidName>M</MidName>
<Family>Pashaiasl</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Reproductive Biology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Department of Reproductive Biology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email>pashaim@tbzmed.ac.ir</Email>
</EMAILS>
</AUTHOR>
    </AUTHORS>
    <KEYWORDS>
        <KEYWORD><KeyText>Cumulus cells</KeyText></KEYWORD><KEYWORD><KeyText>Letrozole</KeyText></KEYWORD><KEYWORD><KeyText>N-acetylcysteine</KeyText></KEYWORD><KEYWORD><KeyText>PFKP genes</KeyText></KEYWORD><KEYWORD><KeyText>PKM2 genes</KeyText></KEYWORD><KEYWORD><KeyText>Polycystic ovarian syndrome</KeyText></KEYWORD>
    </KEYWORDS>
    <PDFFileName>140264.pdf</PDFFileName>
    <REFRENCES>
        <REFRENCE>
            <REF>Thakker D, Raval A, Patel I, Walia R. N‐acetylcysteine for polycystic ovary syndrome: a systematic review and meta‐analysis of randomized controlled clinical trials. Obstet Gynecol Int. 2015;2015:817849.##Puttabyatappa M, Al-Alem LF, Zakerkish F, Rosewell KL, Br&#228;nnstr&#246;m M, Curry Jr TE. Induction of tissue factor pathway inhibitor 2 by hCG regulates periovulatory gene expression and plasmin activity. Endocrinology. 2017;158(1):109-20.##Azziz R, Kintziger K, Li R, Laven J, Morin-Papunen L, Merkin SS, et al.  Recommendations for epidemiologic and phenotypic research in polycystic ovary syndrome: an androgen excess and PCOS society resource. Hum Reprod. 2019;34(11):2254-65. ##Alsaadi YL, Mohamad BJ. Prevalence of hyperandrogenism in Iraqi women with polycystic ovary syndrome. Iraqi J Sci. 2019:2600-8.##Jeelani H, Ganie MA, Masood A, Amin S, Kawa IA, Fatima Q, et al. Assessment of PON1 activity and circulating TF levels in relation to BMI, testosterone, HOMA-IR, HDL-C, LDL-C, CHO, SOD activity and TAC in women with PCOS: an observational study. Diabetes Metab Syndr. 2019;13(5):2907-15.##Basirat Z, Rad HA, Esmailzadeh S, Jorsaraei SG, Hajian-Tilaki K, Pasha H, et al. Comparison of pregnancy rate between fresh embryo transfers and frozen-thawed embryo transfers following ICSI treatment. Int J Reprod Biomed. 2016;14(1):39-46.##Zhu Z, Fan X, Lv Y, Zhang N, Fan C, Zhang P, Zeng W. Vitamin E analogue improves rabbit sperm quality during the process of cryopreservation through its antioxidative action. PloS One. 2015;10(12):e0145383.##Rad HA, Sefidgar SA, Tamadoni A, Sedaghat S, Bakouei F, Bijani A, et al. Obesity and iron-deficiency anemia in women of reproductive age in northern Iran. J Educ Health Promot. 2019;8:115.##Mostajeran F, Gasemi Tehrani H, Rahbary B. N-ac-etylcysteine as an adjuvant to letrozole for induction of ovulation in infertile patients with polycystic ovary syndrome. Adv 	Biomed Res. 2018;7:100.##Martinez CA, Rizos D, Rodriguez-Martinez H, Funahashi H. Oocyte-cumulus cells crosstalk: new comparative insights. Theriogenology. 2023;205:87-93.##Shetty R, Udupa N, Mutalik S, Kulkarni V, Rao V. Mechanisms and therapeutics of n-acetylcysteine: a recent update. Res J Pharm Technol. 2019;12(5):2584-8.##Galindo C, Latypova L, Barshtein G, Livshits L, Arbell D, Einav S, et al. The inhibition of glucose uptake to erythrocytes: microwave dielectric response. Eur Biophysics J. 2022;51(4-5):353-63.##Racowsky C, Needleman DJ. Cumulus cell gene expression as a potential biomarker for oocyte quality. Fertil Steril. 2018;109(3):438-9.##Hu S, Yu Q, Wang Y, Wang M, Xia W, Zhu C. Letrozole versus clomiphene citrate in polycystic ovary syndrome: a meta-analysis of randomized controlled trials. Arch Gynecol Obstet. 2018;297(5):1081-8.##Franik S, Eltrop SM, Kremer JA, Kiesel L, Farquhar C. Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2018;5(5):CD010287.##Nikiforov D, Gr&#248;ndahl ML, Hreinsson J, Andersen CY. Human oocyte morphology and outcomes of infertility treatment: a systematic review. Reprod Sci. 2022;29(10):2768-85.##Garde J, Roldan ER. S Stimulation of Ca(2 )-dependent exocytosis of the sperm acrosome by cAMP acting downstream of phospholipase A2. J Reprod Fertil. 2000;118(1):57-68.##Pan Y, Pan C, Zhang C. Unraveling the complexity of follicular fluid: insights into its composition, function, and clinical implications. J Ovarian Res. 2024;17(1):237.##Kong P, Yin M, Tang C, Zhu X, Bukulmez O, Chen M, et al. Effects of early cumulus cell removal on treatment outcomes in patients undergoing in vitro fertilization: a retrospective cohort study. Front Endocrinol (Lausanne). 2021;12:669507.##Stocker WA, Walton KL, Richani D, Chan KL, Beilby KH, Finger BJ, et al, A variant of human growth differentiation factor-9 that improves oocyte developmental competence. J Biol Chem. 2020;295(23):7981-91.##Nix J, Marrella MA, Oliver MA, Rhoads M, Ealy AD, Biase FH. Cleavage kinetics is a better indicator of embryonic developmental competency than brilliant cresyl blue staining of oocytes. Anim Reprod Sci. 2023;248:107174.##Wen J, Wang GL, Yuan HJ, Zhang J, Xie HL, Gong S, et al. Effects of glucose metabolism pathways on nuclear and cytoplasmic maturation of pig oocytes. Sci Rep. 2020;10(1):2782.##Schultz RM, Stein P, Svoboda P. The oocyte-to-embryo transition in mouse: past, present, and future. Biol Reprod. 2018;99(1):160-74.##Gorshinova VK, Tsvirkun DV, Sukhanova IA, Tarasova NV, Volodina MA, Marey MV, et al. Cumulus cell mitochondrial activity in relation to body mass index in women undergoing assisted reproductive therapy. BBA Clin. 2017;7:141-6.##Nishihara T, Matsumoto K, Hosoi Y, Morimoto Y. Evaluation of antioxidant status and oxidative stress markers in follicular fluid for human in vitro fertilization outcome. Reprod Med Biol. 2018;17(4):481-6.##Turathum B, Gao EM, Chian RC. The function of cumulus cells in oocyte growth and maturation and in subsequent ovulation and fertilization. Cells. 2021;10(9):2292.##Scarica C, Cimadomo D, Dovere L, Giancani A, Stoppa M, Capalbo A, et al. An integrated investigation of oocyte developmental competence: expression of key genes in human cumulus cells, morphokinetics of early divisions, blastulation, and euploidy. J Assist Reprod Genet. 2019;36(5):875-87.##Wyse BA, Fuchs Weizman N, Kadish S, Balakier H, Sangaralingam M, Librach CL. Transcriptomics of cumulus cells–a window into oocyte maturation in humans. J Ovarian Res. 2020;13(1):93.##Macut D, Bjekić-Macut J, Savić-Radojević A. Dyslipidemia and oxidative stress in PCOS. Front Horm Res. 2013;40:51-63.##Lu J, Wang Z, Cao J, Chen Y, Dong Y. A novel and compact review on the role of oxidative stress in female reproduction. Reprod Biol Endocrinol. 2018;16(1):80.##Jo&#243; JG, Sulyok E, B&#243;dis J, Kornya L. Disrupted balance of the oxidant–antioxidant system in the pathophysiology of female reproduction: oxidative stress and adverse pregnancy outcomes. Curr Issues Mol Biol. 2023;45(10):8091-111.##Liu Y, Yu Z, Zhao S, Cheng L, Man Y, Gao X, et al. Oxidative stress markers in the follicular fluid of patients with polycystic ovary syndrome correlate with a decrease in embryo quality. J Assist Reprod Genet. 2021;38(2):471-7.##Pashaei-Asl R, Pashaiasl M, Ebrahimie E, Ataei ML, Paknejad M. Apoptotic effects of human amniotic fluid mesenchymal stem cells conditioned medium on human MCF-7 breast cancer cell line. Bioimpacts. 2023;13(3):191-206.##Vi&#241;a I, Vi&#241;a JR, Carranza M, Mariscal G. Efficacy of n-acetylcysteine in polycystic ovary syndrome: systematic review and meta-analysis. Nutrients. 2025;17(2):284.##Mostajeran F, Tehrani HG, Rahbary B. N-acetylcysteine as an adjuvant to letrozole for induction of ovulation in infertile patients with polycystic ovary syndrome. Adv Biomed Res. 2018;7:100.##Vi&#241;a I, Vi&#241;a JR, Carranza M, Mariscal G. Efficacy of n-acetylcysteine in polycystic ovary syndrome: systematic review and meta-analysis. Nutrients. 2025;17(2):284.##Liu J, Su H, Jin X, Wang L, Huang J. The effects of n-acetylcysteine supplement on metabolic parameters in women with polycystic ovary syndrome: a systematic review and meta-analysis. Front Nutr. 2023;10:1209614.##Morgan D, Garg M, Tergaonkar V, Tan SY, Sethi G. Pharmacological significance of the non-canonical NF-κB pathway in tumorigenesis. Biochim Biophys Acta Rev Cancer. 2020;1874(2):188449.##Loukili N, Rosenblatt-Velin N, Rolli J, Levrand S, Feihl F, Waeber B, et al. Oxidants positively or negatively regulate nuclear factor kappaB in a context-dependent manner. J Biol Chem. 2010;285(21):15746-52.##Teimouri B, Mollashahi S, Paracheh M, Farzaneh F. Comparison of the effect of letrozole alone with letrozole plus n-acetylcysteine on pregnancy rate in patients with polycystic ovarian syndrome: a randomized clinical trial. Int J Womens Health Reprod Sci. 2021;9(1):75-79.##Yifu P. A review of antioxidant n-acetylcysteine in addressing polycystic ovary syndrome. Gynecol Endocrinol. 2024;40(1):2381498.##Lee YB, Min JK, Kim JG, Cap KC, Islam R, Hossain AJ, et al. Multiple functions of pyruvate kinase M2 in various cell types. J Cell Physiol. 2022;237(1):128-48.##Chen X, Chen Sh, Yu D. Protein kinase function of pyruvate kinase M2 and cancer. Cancer Cell Int. 2020;20(1):523.##Wathlet S, Adriaenssens T, Segers I, Verheyen G, Janssens R, Coucke W, et al. New candidate genes to predict pregnancy outcome in single embryo transfer cycles when using cumulus cell gene expression. Fertil Steril. 2012;98(2):432-9.e1-4.##</REF>
        </REFRENCE>
    </REFRENCES>
</ARTICLE>

<ARTICLE>
    <TitleF></TitleF>
    <TitleE>Prognostic Factors for Pain and Fertility Outcomes Following Laparoscopic Endometriosis Surgery: A Single-Center Experience</TitleE>
    <TitleLang_ID>2</TitleLang_ID>
    <ABSTRACTS>
        <ABSTRACT>
            <Language_ID>1</Language_ID>
            <CONTENT>140267</CONTENT>
        </ABSTRACT>
        <ABSTRACT>
            <Language_ID>2</Language_ID>
            <CONTENT>&lt;p&gt;Background: Endometriosis is a prevalent condition among women, often leading to infertility. Laparoscopic surgery is widely employed as a therapeutic intervention for endometriosis. This study investigated the prognostic factors influencing the outcome of laparoscopic surgery for endometriosis.&#160;&lt;br /&gt;
Methods: This cross-sectional study included 60 women with endometriosis referred for laparoscopic surgery at Amiralmomenin Hospital, Zabol, Iran, between 2022 and 2024. Pain intensity was measured using a visual analog scale (VAS). Statistical analyses were performed using SPSS version 26. Descriptive statistics summarized the data, while univariate analyses (t-tests and chi-square tests) assessed relationships between variables. Multivariate logistic regression identified independent predictors of pain reduction and pregnancy outcomes.&lt;br /&gt;
Results: Patients with moderate endometriosis showed statistically significant pain reduction from 8.8 preoperatively to 1.8 at 9 months (p&lt;0.001) and 2.2 at 12 months post-surgery (p=0.003). Those with severe endometriosis had non-significant pain reduction (8 to 6 at 12 months, p=0.12). Both intrauterine (9 to 1.1 at 12 months, p&lt;0.001) and extrauterine involvement groups (8.6 to 3.3, p=0.004) demonstrated significant pain improvement, with no significant difference between the groups (p=0.779). Regarding fertility outcomes, treatment before the age of 30 significantly increased pregnancy likelihood (AOR=20.57, 95%CI 1.4-295.3), while other factors including BMI, CA125 levels, and parity showed no significant associations (all p&gt;0.05).&lt;br /&gt;
Conclusion: These preliminary findings suggest that laparoscopic surgery may reduce pain in moderate endometriosis, while the age under 30 may be associated with improved pregnancy outcomes. However, given the study’s limited sample size and wide confidence intervals, these results require validation in larger, multicenter cohorts.&lt;/p&gt;</CONTENT>
        </ABSTRACT>
    </ABSTRACTS>
    <PAGES>
        <PAGE>
            <FPAGE>090</FPAGE>
            <TPAGE>98</TPAGE>
        </PAGE>
    </PAGES>
    <AUTHORS>
        <AUTHOR>
<Name>Mania</Name>
<MidName>M</MidName>
<Family>Kaveh</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Obstetrics and Gynecology, School of Medicine, Amiralmomenin Hospital, Zabol University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Department of Obstetrics and Gynecology, School of Medicine, Amiralmomenin Hospital, Zabol University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Fatemeh</Name>
<MidName>F</MidName>
<Family>Khodayari</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Obstetrics and Gynecology, School of Medicine, Amiralmomenin Hospital, Zabol University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Department of Obstetrics and Gynecology, School of Medicine, Amiralmomenin Hospital, Zabol University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Shahla</Name>
<MidName>Sh</MidName>
<Family>Chaichian</Family>
<NameE>Shahla</NameE>
<MidNameE></MidNameE>
<FamilyE>Chaichian</FamilyE>
<Organizations>
<Organization>Endometriosis Research Center, Iran University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Endometriosis Research Center, Iran University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Abolfazl</Name>
<MidName>A</MidName>
<Family>Mehdizadehkashi</Family>
<NameE>Abolfazl</NameE>
<MidNameE></MidNameE>
<FamilyE>Mehdizadehkashi</FamilyE>
<Organizations>
<Organization>Department of Obstetrics and Gynecology, School of Medicine, Endometriosis Research Center, Rasoul Akram Hospital, Iran University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Department of Obstetrics and Gynecology, School of Medicine, Endometriosis Research Center, Rasoul Akram Hospital, Iran University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Mehdi</Name>
<MidName>M</MidName>
<Family>Afshari</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Community Medicine, School of Medicine, Pediatric Gastroenterology and Hepatology Research Center, Zabol University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Department of Community Medicine, School of Medicine, Pediatric Gastroenterology and Hepatology Research Center, Zabol University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Zahra</Name>
<MidName>Z</MidName>
<Family>Shahraki</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Obstetrics and Gynecology, School of Medicine, Amiralmomenin Hospital, Zabol University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Department of Obstetrics and Gynecology, School of Medicine, Amiralmomenin Hospital, Zabol University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Kambiz</Name>
<MidName>K</MidName>
<Family>Sadegi</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Anesthesiology, School of Medicine, Amiralmomenin Hospital, Zabol University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Department of Anesthesiology, School of Medicine, Amiralmomenin Hospital, Zabol University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email>Kamsadegi@yahoo.co.uk</Email>
</EMAILS>
</AUTHOR>
    </AUTHORS>
    <KEYWORDS>
        <KEYWORD><KeyText>Endometriosis</KeyText></KEYWORD><KEYWORD><KeyText>Laparoscopic surgery</KeyText></KEYWORD><KEYWORD><KeyText>Postoperative pain</KeyText></KEYWORD><KEYWORD><KeyText>Surgical pain management</KeyText></KEYWORD>
    </KEYWORDS>
    <PDFFileName>140267.pdf</PDFFileName>
    <REFRENCES>
        <REFRENCE>
            <REF>[No authors listed]. Practice bulletin no. 114: management of endometriosis. Obstet Gynecol. 2010;116(1):223-36##Bergqvist A. Different types of extragenital endometriosis: a review. Gynecol Endocrinol. 1993;7(3):207-21.##Karlitz JJ, Tepler IA, Tanaka KE. Endometriosis with colonic wall invasion. Clin Gastroenterol Hepatol. 2007;5(3):A30.##Rana R, Sharma S, Narula H, Madhok B. A case of recto-sigmoid endometriosis mimicking carcinoma. Springerplus. 2016;5:643.##Gylfason JT, Kristjansson KA, Sverrisdottir G, Jonsdottir K, Rafnsson V, Geirsson RT. Pelvic endometriosis diagnosed in an entire nation over 20 years. Am J Epidemiol. 2010;172(3):237-43.##Practice committee of the American society for reproductive medicine. Endometriosis and infertility: a committee opinion. Fertil Steril. 2012;98(3):591-8.##Montgomery GW, Giudice LC. New lessons about endometriosis-somatic mutations and disease heterogeneity. New Engl J Med. 2017;376(19):1881-2.##Andres MP, Borrelli GM, Abr&#227;o MS. Endometriosis classification according to pain symptoms: can the ASRM classification be improved? Best Pract Res Clin Obstet Gynaecol. 2018;51:111-8.##Goncalves MOdC, Podgaec S, Dias Jr JA, Gonzalez M, Abrao MS. Transvaginal ultrasonography with bowel preparation is able to predict the number of lesions and rectosigmoid layers affected in cases of deep endometriosis, defining surgical strategy. Hum Reprod. 2010;25(3):665-71.##Kho RM, Andres MP, Borrelli GM, Neto JS, Zanluchi A, Abr&#227;o MS. Surgical treatment of different types of endometriosis: Comparison of major society guidelines and preferred clinical algorithms. Best Pract Res Clin Obstet Gynaecol. 2018;51:102-10.##Menakaya UA, Rombauts L, Johnson NP. Diagnostic laparoscopy in pre‐surgical planning for higher stage endometriosis: Is it still relevant? Aust N Z J Obstet Gynaecol. 2016;56(5):518-22.##Nisenblat V, Bossuyt PM, Farquhar C, Johnson N, Hull ML. Imaging modalities for the non‐invasive diagnosis of endometriosis. Cochrane Database Syst Rev. 2016;2(2):CD009591.##Flyckt R, Kim S, Falcone T. Surgical management of endometriosis in patients with chronic pelvic pain. Semin Reprod Med. 2017;35(1):54-64.##Macer ML, Taylor HS. Endometriosis and infertility: a review of the pathogenesis and treatment of endometriosis-associated infertility. Obstet Gynecol Clin North Am. 2012;39(4):535-49.##Tanbo T, Fedorcsak P. Endometriosis‐associated infertility: aspects of pathophysiological mechanisms and treatment options. Acta Obstet Gynecol Scand. 2017;96(6):659-67.##Singh SS, Suen MW. Surgery for endometriosis: beyond medical therapies. Fertil Steril. 2017;107(3):549-54.##Peterson CM, Johnstone EB, Hammoud AO, Stanford JB, Varner MW, Kennedy A, et al. Risk factors associated with endometriosis: importance of study population for characterizing disease in the ENDO study. Am J Obstet Gynecol. 2013;208(6):451.e1-11.##Smolarz B, Szyłło K, Romanowicz H. Endometriosis: epidemiology, classification, pathogenesis, treatment and genetics (review of literature). Int J Mol Sci. 2021;22(19):10554.##Wenzl R, Kiesel L, Huber JC, Wieser F. Endometriosis: a genetic disease. Drug Today (Bar). 2003;39(12):961-72.##Lemaire GS. More than just menstrual cramps: symptoms and uncertainty among women with endometriosis. J Obstet Gynecol Neonatal Nurs. 2004;33(1):71-9.##Signorile PG, Cassano M, Viceconte R, Spyrou M, Marcattilj V, Baldi A. Endometriosis: a retrospective analysis on diagnostic data in a cohort of 4,401 patients. In Vivo. 2022;36(1):430-8.##Porpora MG, Tomao F, Ticino A, Piacenti I, Scaramuzzino S, Simonetti S, et al. Endometriosis and pregnancy: a single institution experience. Int J Environ Res Public Health. 2020;17(2):401.##Jacobson TZ, Barlow DH, Koninckx PR, Olive D, Farquhar C. Laparoscopic surgery for subfertility associated with endometriosis. Cochrane Database Syst Rev. 2002;4:CD001398.##Marcoux S, Maheux R, B&#233;rub&#233; S, Endometriosis CCGo. Laparoscopic surgery in infertile women with minimal or mild endometriosis. New Engl J Med. 1997;337(4):217-22.##Moini A, Malekzadeh F, Amirchaghmaghi E, Kashfi F, Akhoond MR, Saei M, et al. Risk factors associated with endometriosis among infertile Iranian women. Arch Med Sci. 2013;9(3):506-14.##Inoue M. [Treatment of endometriosis associated infertility]. Nihon Sanka Fujinka Gakkai Zasshi. 1989;41(8):960-70.##Nademi M, Rasekhi A. Cumulative logit model in endometriosis risks analysis and its severity. Med Sci. 2018;25(9):37-45.##Hemmings R, Rivard M, Olive DL, Poliquin-Fleury J, Gagn&#233; D, Hugo P, et al. Evaluation of risk factors associated with endometriosis. Fertil Steril. 2004;81(6):1513-21.##Shum LK, Bedaiwy MA, Allaire C, Williams C, Noga H, Albert A, et al. Deep dyspareunia and sexual quality of life in women with endometriosis. Sex Med. 2018;6(3):224-33.##Chaichian S, Abolghasemi J, Omidi FN, Rimaz S, Najmi Z, Mehdizadehkashi A, et al. Factors affecting endometriosis in women of reproductive age: the differences between the results of neural network and logistic regression. Shiraz E Med J. 2018;19(9):e62560.##</REF>
        </REFRENCE>
    </REFRENCES>
</ARTICLE>

<ARTICLE>
    <TitleF></TitleF>
    <TitleE>Serum Levels of CCN3 Protein in Iranian Women with Polycystic Ovary Syndrome</TitleE>
    <TitleLang_ID>2</TitleLang_ID>
    <ABSTRACTS>
        <ABSTRACT>
            <Language_ID>1</Language_ID>
            <CONTENT>140270</CONTENT>
        </ABSTRACT>
        <ABSTRACT>
            <Language_ID>2</Language_ID>
            <CONTENT>&lt;p&gt;Background: Polycystic ovary syndrome (PCOS) is a heterogeneous condition that encompasses several cardiometabolic and endocrinological disorders. Studies have shown that its pathogenesis aligns with several underlying mechanisms associated with recurrent pregnancy loss (RPL). Cellular communication network (CCN)-3 protein is a well-studied adipokine involved in tumorigenesis, organogenesis, inflammation, fibrosis, and glucose metabolism. The purpose of the current study was to determine the association of CCN3 levels with a number of parameters involved in PCOS pathogenesis.&lt;br /&gt;
Methods: This is a case-control study including 120 PCOS patients (60 cases with RPL; PCOS-RPL and 60 cases with infertility; PCOS-Inf and 60 healthy controls). Circulating levels of homocysteine and high-sensitivity C-reactive protein (hs-CRP), homocysteine, and CCN3 were measured using ELISA kits.&lt;br /&gt;
Results: Circulating levels of CCN3 were significantly elevated in PCOS-RPL and PCOS-Inf subgroups when compared to the control group (7.61&#177;3.03 and 6.85&#177;2.54 vs. 3.12&#177;0.82, p&lt;0.001). Serum CCN3 positively correlated with fasting insulin and homeostatic model assessment of insulin resistance (HOMA-IR) in the control group (p&lt;0.05) and PCOS group (p&lt;0.001). Moreover, CCN3 was significantly associated with PCOS (OR 4.808, 95%CI [2.744-8.423], p&lt;0.001).&lt;br /&gt;
Conclusion: According the results of this study CCN3 may be involved in the pathogenesis of PCOS. However, future studies are needed to evaluate the possibility of utilizing CCN3 in the diagnosis and treatment of the disease.&lt;/p&gt;</CONTENT>
        </ABSTRACT>
    </ABSTRACTS>
    <PAGES>
        <PAGE>
            <FPAGE>098</FPAGE>
            <TPAGE>109</TPAGE>
        </PAGE>
    </PAGES>
    <AUTHORS>
        <AUTHOR>
<Name>Akram</Name>
<MidName>A</MidName>
<Family>Vatannejad</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Comparative Biosciences, Faculty of Veterinary Medicine, University of Tehran</Organization>
</Organizations>
<Universities>
<University>Department of Comparative Biosciences, Faculty of Veterinary Medicine, University of Tehran</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email>vatannejad@ut.ac.ir</Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Fatima Zahraa</Name>
<MidName>FZ</MidName>
<Family>Fouani</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical  Sciences</Organization>
</Organizations>
<Universities>
<University>Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical  Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Reza</Name>
<MidName>R</MidName>
<Family>Fadaei</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Sleep Disorders Research Center, Kermanshah University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Sleep Disorders Research Center, Kermanshah University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Asma</Name>
<MidName>A</MidName>
<Family>Kheirollahi</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Comparative Biosciences, Faculty of Veterinary Medicine, University of Tehran</Organization>
</Organizations>
<Universities>
<University>Department of Comparative Biosciences, Faculty of Veterinary Medicine, University of Tehran</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Soheila</Name>
<MidName>S</MidName>
<Family>Ansaripour</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR</Organization>
</Organizations>
<Universities>
<University>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Maryam</Name>
<MidName>M</MidName>
<Family>Shabani Nashtaei</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Infertility, Shariati Hospital, Tehran University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Department of Infertility, Shariati Hospital, Tehran University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Nariman</Name>
<MidName>N</MidName>
<Family>Moradi</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Liver and Digestive Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Liver and Digestive Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Hossein</Name>
<MidName>H</MidName>
<Family>Montakhab-Yeganeh</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Biochemistry, Faculty of Medicine, Hormozgan University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Department of Biochemistry, Faculty of Medicine, Hormozgan University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Faezeh</Name>
<MidName>F</MidName>
<Family>Fattahi</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Emergency Department, Shahid Fayazbakhsh Hospital</Organization>
</Organizations>
<Universities>
<University>Emergency Department, Shahid Fayazbakhsh Hospital</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Farah</Name>
<MidName>F</MidName>
<Family>Jadidizadeh</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Emergency Department, Shahid Fayazbakhsh Hospital</Organization>
</Organizations>
<Universities>
<University>Emergency Department, Shahid Fayazbakhsh Hospital</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR>
    </AUTHORS>
    <KEYWORDS>
        <KEYWORD><KeyText>Abortion</KeyText></KEYWORD><KEYWORD><KeyText>C-reactive protein</KeyText></KEYWORD><KEYWORD><KeyText>Homocysteine</KeyText></KEYWORD><KEYWORD><KeyText>Metabolic syndrome</KeyText></KEYWORD><KEYWORD><KeyText>Nephroblastoma overexpressed protein</KeyText></KEYWORD><KEYWORD><KeyText>Polycystic ovarian syndrome</KeyText></KEYWORD><KEYWORD><KeyText>CCN3</KeyText></KEYWORD>
    </KEYWORDS>
    <PDFFileName>140270.pdf</PDFFileName>
    <REFRENCES>
        <REFRENCE>
            <REF>Villa J, Pratley RE. Adipose tissue dysfunction in polycystic ovary syndrome. Curr Diab Rep. 2011;11(3):179-84.##Ehrmann DA. Polycystic ovary syndrome. N Engl J Med. 2005;352(12):1223-36.##Sam S, Tasali E. Role of obstructive sleep apnea in metabolic risk in PCOS. Curr Opin Endocr Metab Res. 2021;17:46-51.##Nehir Aytan A, Bastu E, Demiral I, Bulut H, Dogan M, Buyru F. Relationship between hyperandrogenism, obesity, inflammation and polycystic ovary syndrome. Gynecol Endocrinol. 2016;32(9):709-13.##Tan BK, Chen J, Hu J, Amar O, Mattu HS, Adya R, et al. Metformin increases the novel adipokine cartonectin/CTRP3 in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2013;98(12):E1891-900.##Shanaki M, Moradi N, Fadaei R, Zandieh Z, Shabani P, Vatannejad A. Lower circulating levels of CTRP12 and CTRP13 in polycystic ovarian syndrome: irrespective of obesity. PloS One. 2018;13(12):e0208059##Calan M, Alan M, Alarslan P, Unal Kocabas G, Bozkaya G, Acara AC, et al. Association of decreased C1q/tumor necrosis factor-related protein-5 levels with metabolic and hormonal disturbance in polycystic ovary syndrome. J Turk Ger Gynecol Assoc. 2019;20(2):89-96.##G&#246;z&#252;k&#252;&#231;&#252;k M, Yarcı G&#252;rsoy A, Desteg&#252;l E, Taşkın S, Şatıroğlu H. Adiponectin and leptin levels in normal weight women with polycystic ovary syndrome. Horm Mol Biol Clin Investig. 2020;41(4).##Sadeghi A, Fadaei R, Moradi N, Fouani FZ, Roozbehkia M, Zandieh Z, et al. Circulating levels of C1q/TNF-alpha-related protein 6 (CTRP6) in polycystic ovary syndrome. IUBMB Life. 2020;72(7):1449-59.##Fouani FZ, Fadaei R, Moradi N, Zandieh Z, Ansaripour S, Yekaninejad MS, et al. Circulating levels of meteorin-like protein in polycystic ovary syndrome: a case-control study. PLoS One. 2020;15(4):e0231943.##Serazin V, Duval F, Wainer R, Ravel C, Vialard F, Molina-Gomes D, et al. Are leptin and adiponectin involved in recurrent pregnancy loss? J Obstet Gynaecol Res. 2018;44(6):1015-22.##Dos Santos E, Serazin V, Morvan C, Torre A, Wainer R, de Mazancourt P, et al. Adiponectin and leptin systems in human endometrium during window of implantation. Fertil Steril. 2012;97(3): 771-8.e1.##Kim HS, Nagalla SR, Oh Y, Wilson E, Roberts CT Jr, Rosenfeld RG. Identification of a family of low-affinity insulin-like growth factor binding proteins (IGFBPs): characterization of connective tissue growth factor as a member of the IGFBP superfamily. Proc Natl Acad Sci USA. 1997;94 (24):12981-6.##Perbal B. Nuclear localisation of NOVH protein: a potential role for NOV in the regulation of gene expression. Mol Pathol. 1999;52(2):84-91.##Perbal B. Contribution of MAV-1-induced nephroblastoma to the study of genes involved in human Wilms&#39; tumor development. Crit Rev Oncog. 1994;5(6):589-613.##Sakamoto K, Yamaguchi S, Ando R, Miyawaki A, Kabasawa Y, Takagi M, et al. The nephroblastoma overexpressed gene (NOV/ccn3) protein associates with Notch1 extracellular domain and inhibits myoblast differentiation via Notch signaling pathway. J Biol Chem. 2002;277(33):29399-405.##Li CL, Martinez V, He B, Lombet A, Perbal B. A role for CCN3 (NOV) in calcium signalling. Mol Pathol. 2002;55(4):250-61.##Su BY, Cai WQ, Zhang CG, Su HC, Perbal B. A developmental study of novH gene expression in human central nervous system. C R Acad Sci III. 1998;321(11):883-92.##Burren CP, Wilson EM, Hwa V, Oh Y, Rosenfeld RG. Binding properties and distribution of insulin-like growth factor binding protein-related protein 3 (IGFBP-rP3/NovH), an additional member of the IGFBP superfamily. J Clin Endocrinol Metab. 1999;84(3):1096-103.##Gupta N, Wang H, McLeod TL, Naus CC, Kyurkchiev S, Advani S, et al. Inhibition of glioma cell growth and tumorigenic potential by CCN3 (NOV). Mol Pathol. 2001;54(5):293-9.##Maillard M, Cadot B, Ball RY, Sethia K, Edwards DR, Perbal B, et al. Differential expression of the ccn3 (nov) proto-oncogene in human prostate cell lines and tissues. Mol Pathol. 2001;54(4):275-80.##Martinerie C, Gicquel C, Louvel A, Laurent M, Schofield PN, Le Bouc Y. Altered expression of novH is associated with human adrenocortical tumorigenesis. J Clin Endocrinol Metab. 2001;86(8):3929-40.##Manara MC, Perbal B, Benini S, Strammiello R, Cerisano V, Perdichizzi S, et al. The expression of ccn3(nov) gene in musculoskeletal tumors. Am J Pathol. 2002;160(3):849-59.##Yu C, Le AT, Yeger H, Perbal B, Alman BA. NOV (CCN3) regulation in the growth plate and CCN family member expression in cartilage neoplasia. J Pathol. 2003;201(4):609-15.##Thibout H, Martinerie C, Cr&#233;minon C, Godeau F, Boudou P, Le Bouc Y, et al. Characterization of human NOV in biological fluids: an enzyme immunoassay for the quantification of human NOV in sera from patients with diseases of the adrenal gland and of the nervous system. J Clin Endocrinol Metab. 2003;88(1):327-36.##Jiang WG, Watkins G, Fodstad O, Douglas-Jones A, Mokbel K, Mansel RE. Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer. Endocr Relat Cancer. 2004;11(4):781-91.##Lafont J, Jacques C, Le Dreau G, Calhabeu F, Thibout H, Dubois C, et al. New target genes for NOV/CCN3 in chondrocytes: TGF-beta2 and type X collagen. J Bone Miner Res. 2005;20(12):2213-23.##Giusti V, Scotlandi K. CCN proteins in the musculoskeletal system: current understanding and challenges in physiology and pathology. J Cell Commun Signal. 2021;15(4):545-66.##Kubota S, Kawaki H, Perbal B, Kawata K, Hattori T, Nishida T. Cellular communication network factor 3 in cartilage development and maintenance. J Cell Commun Signal. 2021;15(4):533-43.##Son S, Kim H, Lim H, Lee JH, Lee KM, Shin I. CCN3/NOV promotes metastasis and tumor progression via GPNMB-induced EGFR activation in triple-negative breast cancer. Cell Death Dis. 2023;14(2):81.##Yan X, Yan W, Fu X, Xu Y, Zhu N, Qiu C, et al. Single nucleotide mutation changes the capability of CCN3 in osteosarcoma cell invasion and differentiation. Transl Oncol. 2022;24:101485.##Li JY, Wang YD, Qi XY, Ran L, Hong T, Yang J, et al. Serum CCN3 levels are increased in type 2 diabetes mellitus and associated with obesity, insulin resistance and inflammation. Clin Chim Acta. 2019;494:52-7.##Shi H, Zhang C, Pasupuleti V, Hu X, Prosdocimo DA, Wu W, et al. CCN3 Regulates Macrophage Foam Cell Formation and Atherosclerosis. Am J Pathol. 2017;187(6):1230-7.##Martinerie C, Garcia M, Do TT, Antoine B, Moldes M, Dorothee G, et al. NOV/CCN3: a new adipocytokine involved in obesity-associated insulin resistance. Diabetes. 2016;65(9):2502-15.##Cao J, Singh SP, McClung JA, Joseph G, Vanella L, Barbagallo I, et al. EET intervention on Wnt1, NOV, and HO-1 signaling prevents obesity-induced cardiomyopathy in obese mice. Am J Physiol Heart Circ Physiol. 2017;313(2):H368-80.##Henrot P, Moisan F, Laurent P, Manicki P, Kaulanjan-Checkmodine P, Jolivel V, et al. Decreased CCN3 in systemic sclerosis endothelial cells contributes to impaired angiogenesis. J Invest Dermatol. 2020;140(7):1427-34.e5.##Naughton M, Moffat J, Eleftheriadis G, de la Vega Gallardo N, Young A, Falconer J, et al. CCN3 is dynamically regulated by treatment and disease state in multiple sclerosis. J Neuroinflammation. 2020;17(1):349.##Wei Y, Peng L, Li Y, Zhang N, Shang K, Duan L, et al. Higher serum CCN3 is associated with disease activity and inflammatory markers in rheumatoid arthritis. J Immunol Res. 2020;2020:3891425.##Weingarten JA, Bellner L, Peterson SJ, Zaw M, Chadha P, Singh SP, et al. The association of NOV/CCN3 with obstructive sleep apnea (OSA): preliminary evidence of a novel biomarker in OSA. Horm Mol Biol Clin Investig. 2017;31(2).##Tu P, Xu Q, Zhou X, Villa-Roel N, Kumar S, Dong N, et al. Myeloid CCN3 protects against aortic valve calcification. Cell Commun Signal. 2023;21(1):14.##Flinn MA, Alvarez-Argote S, Knas MC, Almeida VA, Paddock SJ, Zhou X, et al. Myofibroblast Ccn3 is regulated by Yap and Wwtr1 and contributes to adverse cardiac outcomes. Front Cardiovasc Med. 2023;10:1142612.##Gellhaus A, Schmidt M, Dunk C, Lye SJ, Kimmig R, Winterhager E. Decreased expression of the angiogenic regulators CYR61 (CCN1) and NOV (CCN3) in human placenta is associated with pre-eclampsia. Mol Hum Reprod. 2006;12(6):389-99.##Wagener J, Yang W, Kazuschke K, Winterhager E, Gellhaus A. CCN3 regulates proliferation and migration properties in Jeg3 trophoblast cells via ERK1/2, Akt and Notch signalling. Mol Hum Reprod. 2013;19(4):237-49.##Hassani F, Oryan Sh, Eftekhari-Yazdi P, Bazrgar M, Moini A, Nasiri N, et al. Downregulation of extracellular matrix and cell adhesion molecules in cumulus cells of infertile polycystic ovary syndrome women with and without insulin resistance. Cell J. 2019;21(1):35-42.##Sadeghi A, Fadaei R, Moradi N, Fouani FZ, Roozbehkia M, Zandieh Z, et al. Circulating levels of C1q/TNF‐α‐related protein 6 (CTRP6) in polycystic ovary syndrome. IUBMB Life. 2020;72(7):1449-59.##Vatannejad A, Salimi F, Moradi N, Fouani FZ, Zandieh Z, Ansaripour S, et al. Evaluation of angiopoietin-like protein 3 (ANGPTL3) levels in polycystic ovary syndrome. Life Sci. 2020;263:118595.##Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19-25.##Lee RM, Silver RM. Recurrent pregnancy loss: summary and clinical recommendations. Semin Reprod Med. 2000;18(4):433-40.##Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28 (7):412-9.##Connolly A, Leblanc S, Baillargeon JP. Role of lipotoxicity and contribution of the renin-angiotensin system in the development of polycystic ovary syndrome. Int J Endocrinol. 2018;2018:4315413.##Di Sarra D, Tosi F, Bonin C, Fiers T, Kaufman JM, Signori C, et al. Metabolic inflexibility is a feature of women with polycystic ovary syndrome and is associated with both insulin resistance and hyperandrogenism. J Clin Endocrinol Metab. 2013;98(6):2581-8.##Shimoyama T, Hiraoka S, Takemoto M, Koshizaka M, Tokuyama H, Tokuyama T, et al. CCN3 inhibits neointimal hyperplasia through modulation of smooth muscle cell growth and migration. Arterioscler Thromb Vasc Biol. 2010;30(4):675-82.##Ren J, Wang X, Parry SN, Yee C, Gorrell MD, McLennan SV, et al. Targeting CCN2 protects against progressive non-alcoholic steatohepatitis in a preclinical model induced by high-fat feeding and type 2 diabetes. J Cell Commun Signal. 2022;16(3):447-60.##Paradis R, Lazar N, Antinozzi P, Perbal B, Buteau J. Nov/Ccn3, a novel transcriptional target of FoxO1, impairs pancreatic β-cell function. PLoS One. 2013;8(5):e64957.##Pakradouni J, Le Goff W, Calmel C, Antoine B, Villard E, Frisdal E, et al. Plasma NOV/CCN3 levels are closely associated with obesity in patients with metabolic disorders. PLoS One. 2013;8(6):e66788.##Smina TP, Rabeka M, Viswanathan V. Diabetic foot ulcer as a cause of significant decline in the renal function among south Indian population with type 2 diabetes: role of TGF-β1 and CCN family proteins. Int J Low Extrem Wounds. 2019;18(4):354-61.##Riser BL, Najmabadi F, Garchow K, Barnes JL, Peterson DR, Sukowski EJ. Treatment with the matricellular protein CCN3 blocks and/or reverses fibrosis development in obesity with diabetic nephropathy. Am J Pathol. 2014;184(11):2908-21.##Zheng T, Chen H. Resveratrol ameliorates the glucose uptake and lipid metabolism in gestational diabetes mellitus mice and insulin-resistant adipocytes via miR-23a-3p/ NOV axis. Mol Immunol. 2021;137:163-73.##Wang H, Huang B, Hou A, Xue L, Wang B, Chen J, et al. High NOV/CCN3 expression during high-fat diet pregnancy in mice affects GLUT3 expression and the mTOR pathway. Am J Physiol Endocrinol Metab. 2021;320(4):E786-96.##Sacerdoti D, Singh SP, Schragenheim J, Bellner L, Vanella L, Raffaele M, et al. Development of NASH in obese mice is confounded by adipose tissue increase in inflammatory NOV and oxidative stress. Int J Hepatol. 2018;2018:3484107.##Martinerie C, Garcia M, Do TT, Antoine B, Moldes M, Dorothee G, et al. NOV/CCN3: a new adipocytokine involved in obesity-associated insulin resistance. Diabetes. 2016;65(9):2502-15.##Abd El Kader T, Kubota S, Janune D, Nishida T, Hattori T, Aoyama E, et al. Anti-fibrotic effect of CCN3 accompanied by altered gene expression profile of the CCN family. J Cell Commun Signal. 2013;7(1):11-8.##Akashi S, Nishida T, El-Seoudi A, Takigawa M, Iida S, Kubota S. Metabolic regulation of the CCN family genes by glycolysis in chondrocytes. J Cell Commun Signal. 2018;12(1):245-52.##Escot&#233; X, G&#243;mez-Zorita S, L&#243;pez-Yoldi M, Milton-Laskibar I, Fern&#225;ndez-Quintela A, Mart&#237;nez JA, et al. Role of omentin, vaspin, cardiotrophin-1, TWEAK and NOV/CCN3 in obesity and diabetes development. Int J Mol Sci. 2017;18(8):1770.##Trepiana J, G&#243;mez-Zorita S, Fern&#225;ndez-Quintela A, Gonz&#225;lez M, Portillo MP. Effects of resveratrol and its analogue pterostilbene, on NOV/CCN3 adipokine in adipose tissue from rats fed a high-fat high-sucrose diet. J Physiol Biochem. 2019;75(3):275-83.##Singh SP, McClung JA, Bellner L, Cao J, Waldman M, Schragenheim J, et al. CYP-450 epoxygenase derived epoxyeicosatrienoic acid contribute to reversal of heart failure in obesity-induced diabetic cardiomyopathy via PGC-1 α activation. Cardiovasc Pharm Open Access. 2018;7(1):233.##Schragenheim J, Bellner L, Cao J, Singh SP, Bamshad D, McClung JA, et al. EET enhances renal function in obese mice resulting in restoration of HO-1-Mfn1/2 signaling, and decrease in hypertension through inhibition of sodium chloride co-transporter. Prostaglandins Other Lipid Mediat. 2018;137:30-9.##Shen SH, Singh SP, Raffaele M, Waldman M, Hochhauser E, Ospino J, et al. Adipocyte-specific expression of PGC1α promotes adipocyte browning and alleviates obesity-induced metabolic dysfunction in an HO-1-dependent fashion. Antioxidants (Basel). 2022;11(6):1147.##Waldman M, Singh SP, Shen HH, Alex R, Rezzani R, Favero G, et al. Silencing the adipocytokine NOV: a novel approach to reversing oxidative stress-induced cardiometabolic dysfunction. Cells. 2022;11(19):3060.##Seow KM, Lin YH, Hwang JL, Wang PH, Ho LT, Lin YH, et al. Expression levels of haem oxygenase-1 in the omental adipose tissue and peripheral blood mononuclear cells of women with polycystic ovary syndrome. Hum Reprod. 2011;26(2):431-7.##Gao H, Meng J, Xing H, Nie S, Xu M, Zhang S, et al. Association of heme oxygenase-1 with the risk of polycystic ovary syndrome in non-obese women. Hum Reprod. 2014;29(5):1058-66.##Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol. 2011;29:415-45.##Maleedhu P, Vijayabhaskar M, Sharma SSB, Kodumuri PK. Status of homocysteine in polycystic ovary syndrome (PCOS). J Clin Diagn Res. 2014;8(2):31-3.##Asanidze E, Kristesashvili J, Andguladze S. Correlation between levels of homocysteine, anti-mullerian hormone and insulin resistance in PCOS patients with with recurrent miscarriage. Georgian Med News. 2019(290):25-9.##Wagner MM, Jukema JW, Hermes W, le Cessie S, de Groot CJM, Bakker JA, et al. Assessment of novel cardiovascular biomarkers in women with a history of recurrent miscarriage. Pregnancy Hypertens. 2018;11:129-35.##Kular L, Pakradouni J, Kitabgi P, Laurent M, Martinerie C. The CCN family: a new class of inflammation modulators? Biochimie. 2011;93(3):377-88.##Zhu HP, Huang HY, Wu DM, Dong N, Dong L, Chen CS, et al. Regulatory mechanism of NOV/CCN3 in the inflammation and apoptosis of lung epithelial alveolar cells upon lipopolysaccharide stimulation. Mol Med Rep. 2020;21(4):1872-80.##Liu J, Ren Y, Kang L, Zhang L. Overexpression of CCN3 inhibits inflammation and progression of atherosclerosis in apolipoprotein E-deficient mice. PLoS One. 2014;9(4):e94912.##Zhang C, van der Voort D, Shi H, Zhang R, Qing Y, Hiraoka S, et al. Matricellular protein CCN3 mitigates abdominal aortic aneurysm. J Clin Investig. 2016;126(4):1282-99.##Bedore J, Sha W, McCann MR, Liu S, Leask A, S&#233;guin CA. Impaired intervertebral disc development and premature disc degeneration in mice with notochord-specific deletion of CCN2. Arthritis Rheum. 2013;65(10):2634-44.##Riser BL, Najmabadi F, Perbal B, Rambow JA, Riser ML, Sukowski E, et al. CCN3/CCN2 regulation and the fibrosis of diabetic renal disease. J Cell Commun Signal. 2010;4(1):39-50.##</REF>
        </REFRENCE>
    </REFRENCES>
</ARTICLE>

<ARTICLE>
    <TitleF></TitleF>
    <TitleE>Altered Expression of Toll-Like Receptors and Key Signaling Genes in Sertoli Cells of Azoospermic Patients</TitleE>
    <TitleLang_ID>2</TitleLang_ID>
    <ABSTRACTS>
        <ABSTRACT>
            <Language_ID>1</Language_ID>
            <CONTENT>140266</CONTENT>
        </ABSTRACT>
        <ABSTRACT>
            <Language_ID>2</Language_ID>
            <CONTENT>&lt;p&gt;Background: Azoospermia, the complete absence of sperm in the ejaculate, is a major cause of male infertility. Sertoli cells are essential for spermatogenesis, and disruptions in innate immune immune pathways, particularly Toll-like receptors (TLRs), may impair their function. This study investigated the expression of TLR1–10 and downstream signaling molecules (MYD88, NFKB, TRIF, IRF3, and TRAM) in Sertoli cells of azoospermic patients.&lt;br /&gt;
Methods: Testicular tissue were collected from 20 azoospermic men undergoing testicular sperm extraction (TESE). Patients were categorized into two TESE positive (sperm present, n=10) and TESE negative (sperm absent, n=10). Sertoli cells were isolated using enzyme digestion and purified via fluorescence-activated cell sorting (FACS). Gene expression of TLR1–10 and signaling molecules was quantified by RT-PCR. Data were analyzed using independent-samples T-test, with significance set at p&lt;0.05.&#160;&lt;br /&gt;
Results: Significant downregulation was detected in TLR10 (20.6-fold, p&lt;0.0001), TLR9 (4.6-fold, p&lt;0.05), TLR7 (4.8-fold, p&lt;0.01), TLR6 (12.4-fold, p&lt;0.05), TLR5 (13.5-fold, p&lt;0.001), TLR4 (3.2-fold, p&lt;0.05), and TLR3 (3.1-fold, p&lt;0.01). Among signaling molecules, MYD88 (4.1-fold, p&lt;0.01) and IRF3 (4.2-fold, p&lt;0.05) showed significant reductions, indicating impaired immune signaling in Sertoli cells of TESE-negative men.&lt;br /&gt;
Conclusion: Altered expression of TLRs and associated signaling molecules in Sertoli cells of azoospermic men suggests innate immune dysregulation as a potential mecha-nism underlying defective spermatogenesis. These findings highlight immune privilege-associated pathways as possible targets for developing diagnostic biomarkers and novel therapeutic approaches for male infertility.&lt;/p&gt;</CONTENT>
        </ABSTRACT>
    </ABSTRACTS>
    <PAGES>
        <PAGE>
            <FPAGE>109</FPAGE>
            <TPAGE>119</TPAGE>
        </PAGE>
    </PAGES>
    <AUTHORS>
        <AUTHOR>
<Name>Mohammad Reza</Name>
<MidName>MR</MidName>
<Family>Lakpour</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Biology, Payame Noor University</Organization>
</Organizations>
<Universities>
<University>Department of Biology, Payame Noor University</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Reza</Name>
<MidName>R</MidName>
<Family>Aflatoonian</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Endocrinology and Female Infertility, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR</Organization>
</Organizations>
<Universities>
<University>Department of Endocrinology and Female Infertility, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Mohammad Ali</Name>
<MidName>MA</MidName>
<Family>Sadighi Gilani</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Andrology, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR</Organization>
</Organizations>
<Universities>
<University>Department of Andrology, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Reza</Name>
<MidName>R</MidName>
<Family>Hajihosseini</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Biology, Payame Noor University</Organization>
</Organizations>
<Universities>
<University>Department of Biology, Payame Noor University</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email>hosseini@pnu.ac.ir</Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Marjan</Name>
<MidName>M</MidName>
<Family>Sabbaghian</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Andrology, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR</Organization>
</Organizations>
<Universities>
<University>Department of Andrology, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email>m.sabbaghian@royaninstitue.org</Email>
</EMAILS>
</AUTHOR>
    </AUTHORS>
    <KEYWORDS>
        <KEYWORD><KeyText>Azoospermia</KeyText></KEYWORD><KEYWORD><KeyText>Male infertility</KeyText></KEYWORD><KEYWORD><KeyText>Signal transduction</KeyText></KEYWORD><KEYWORD><KeyText>Sertoli cells</KeyText></KEYWORD><KEYWORD><KeyText>TESE</KeyText></KEYWORD><KEYWORD><KeyText>Toll-like receptors</KeyText></KEYWORD>
    </KEYWORDS>
    <PDFFileName>140266.pdf</PDFFileName>
    <REFRENCES>
        <REFRENCE>
            <REF>Datta J, Palmer MJ, Tanton C, Gibson LJ, Jones KG, Macdowall W, et al. Prevalence of infertility and help seeking among 15 000 women and men. Hum Reprod. 2016;31(9):2108-18.##Harris E. Infertility affects 1 in 6 people globally. JAMA. 2023;329(17):1443.##Brugh VM, Matschke HM, Lipshultz LI. Male factor infertility. Endocrinol Metab Clin North Am. 2003;32(3):689-707.##Abangah GH, Rashidian T, Parizad Nasirkandy M, Azami M. A meta-analysis of the prevalence and etiology of infertility in Iran. Int J Fertil Steril. 2023;17(3):160-73.##Bhushan S, Theas MS, Guazzone VA, Jacobo P, Wang M, Fijak M, et al. Immune cell subtypes and their function in the testis. Front Immunol. 2020;11:583304.##Wanjari UR, Gopalakrishnan AV. A review on immunological aspects in male reproduction: an immune cells and cytokines. J Reprod Immunol. 2023;158:103984.##Wong WJ, Khan YS. Histology, Sertoli Cell. Stat-Pearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Nov 14 [cited 2025 Aug 30]. Available from: https://www.ncbi.nlm.nih.gov/bo-oks/NBK560631/.##La HM, Hobbs RM. Mechanisms regulating mammalian spermatogenesis and fertility recovery following germ cell depletion. Cell Mol Life Sci. 2019;76(20):4071-102.##Wang JM, Li ZF, Yang WX, Tan FQ. Follicle-stimulating hormone signaling in Sertoli cells: a licence to the early stages of spermatogenesis. Reprod Biol Endocrinol. 2022;20(1):97.##Washburn RL, Dufour JM. Complementing testicular immune regulation: the relationship between sertoli cells, complement, and the immune response. Int J Mol Sci. 2023;24(4):3371.##Kaur G, Long CR, Dufour JM. Genetically engineered immune privileged Sertoli cells: a new road to cell based gene therapy. Spermatogenesis. 2012;2(1):23-31.##Li D, Wu M. Pattern recognition receptors in health and diseases. Signal Transduct Target Ther. 2021;6(1):291.##Amarante-Mendes GP, Adjemian S, Branco LM, Zanetti LC, Weinlich R, Bortoluci KR. Pattern recognition receptors and the host cell death molecular machinery. Front Immunol. 2018;9:2379.##Chen R, Wang F, Chen Y, Han D. Immune homeostasis and disorder in the testis–roles of sertoli cells. J Reprod Immunol. 2022;152:103625.##Duan T, Du Y, Xing C, Wang HY, Wang RF. Toll-like receptor signaling and its role in cell-mediated immunity. Front Immunol. 2022;13:812774.##Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on toll-like receptors. Nat Immunol. 2010;11(5):373-84.##Ortega-Cava CF, Ishihara S, Rumi MA, Aziz M, Kazumori H, Yuki T, et al. Epithelial toll-like receptor 5 is constitutively localized in the mouse cecum and exhibits distinctive down-regulation during experimental colitis. Clin Vaccine Immunol. 2006;13(1):132-8.##Guillot EP, Edwards LW. Self-locking rocker recliner chair. US Patent 6,750,000. 2004.##Wolf YI, Rogozin IB, Grishin NV, Koonin EV. Genome trees and the tree of life. Trends Genet. 2002;18(9):472-9.##Morino K, Petersen KF, Dufour S, Befroy D, Frattini J, Shatzkes N, et al. Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. J Clin Invest. 2005;115(12):3587-93.##Yang L, Parkin DM, Ferlay J, Li L, Chen Y. Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev. 2005;14(1):243-50.##Aflatoonian R, Tuckerman E, Elliott S, Bruce C, Aflatoonian A, Li T, et al. Menstrual cycle-dependent changes of Toll-like receptors in endometrium. Hum Reprod. 2007;22(2):586-93.##Fazeli A, Bruce C, Anumba DO. Characterization of toll-like receptors in the female reproductive tract in humans. Hum Reprod. 2005;20(5):1372-8.##Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, et al. Identification and expansion of human colon-cancer-initiating cells. Nature. 2007;445(7123):111-5.##Palladino MA, Johnson TA, Gupta R, Chapman JL, Ojha P. Members of the Toll-like receptor family of innate immunity pattern-recognition receptors are abundant in the male rat reproductive tract. Biol Reprod. 2007;76(6):958-64.##Akthar I, Kim Y, Umehara T, Kanno C, Sasaki M, Marey MA, et al. Activation of sperm toll-like receptor 2 induces hyperactivation to enhance the penetration to mucus and uterine glands: a trigger for the uterine inflammatory cascade in cattle. Front Immunol. 2023;14:1319572.##Sandor F, Buc M. Toll-like receptors. I. structure, function and their ligands. Folia Biol (Praha). 2005;51(5):148-57.##Wicherska-Pawłowska K, Wr&#243;bel T, Rybka J. Toll-like receptors (TLRs), nOD-like receptors (NLRs), and RIG-I-like receptors (RLRs) in innate immunity. TLRs, NLRs, and RLRs ligands as immunotherapeutic agents for hematopoietic diseases. Int J Mol Sci. 2021;22(24):13397.##Li K, Qu S, Chen X, Wu Q, Shi M. Promising targets for cancer immunotherapy: TLRs, RLRs, and STING-mediated innate immune pathways. Int J Mol Sci. 2017;18(2):404.##Paone A, Starace D, Galli R, Padula F, De Cesaris P, Filippini A, et al. Toll-like receptor 3 triggers apoptosis of human prostate cancer cells through a PKC-α-dependent mechanism. Carcinogenesis. 2008;29(7):1334-42.##Riccioli A, Starace D, Galli R, Fuso A, Scarpa S, Palombi F, et al. Sertoli cells initiate testicular innate immune responses through TLR activation. J Immunol. 2006;177(10):7122-30.##Scarpino S, Morena AR, Petersen C, Fr&#246;ysa B, S&#246;der O, Boitani C. A rapid method of Sertoli cell isolation by DSA lectin, allowing mitotic analyses. Mol Cell Endocrinol. 1998;146(1-2):121-7.##Washburn RL, Dufour JM. Complementing testicular immune regulation: the relationship between sertoli cells, complement, and the immune response. Int J Mol Sci. 2023;24(4):3371.##Khambata K, Modi DN, Gupta SK. Immunoregulation in the testis and its implication in fertility and infections. Explor Immunol. 2021;1(5):309-24.##Washburn RL, Hibler T, Kaur G, Dufour JM. Sertoli cell immune regulation: a double-edged sword. Front Immunol. 2022;13:913502.##Doğan G, Sandık&#231;ı M, Karagen&#231; L. Stage-specific expression of toll-like receptors in the seminiferous epithelium of mouse testis. Histochem Cell Biol. 2024;162(4):323-35.##Lakpour MR, Koruji M, Shahverdi A, Aghajanpour S, Rajabian Naghandar M, Sadighi Gilani MA, et al. The expression of TLR2 and TLR3 in sertoli cells of azoospermic patients. Cell J. 2017;19(3):375-85.##Nishimura M, Naito S. Tissue-specific mRNA expression profiles of human toll-like receptors and related genes. Biol Pharm Bull. 2005;28(5):886-92.##Zandieh Z, Govahi A, Aghamajidi A, Raoufi E, Amjadi F, Aghajanpour S, et al. TLR-1, TLR-2, and TLR-6 MYD88-dependent signaling pathway: a potential factor in the interaction of high-DNA fragmentation human sperm with fallopian tube epithelial cells. Clin Exp Reprod Med. 2023;50(1):44-52.##Bender AT, Tzvetkov E, Pereira A, Wu Y, Kasar S, Przetak MM, et al. TLR7 and TLR8 differentially activate the IRF and NF-κB pathways in specific cell types to promote inflammation. Immunohorizons. 2020;4(2):93-107.##Deng T, Zhang Y, Chen Q, Yan K, Han D. Toll-like receptor-mediated inhibition of Gas6 and ProS expression facilitates inflammatory cytokine production in mouse macrophages. Immunology. 2012;135(1):40-50.##</REF>
        </REFRENCE>
    </REFRENCES>
</ARTICLE>

<ARTICLE>
    <TitleF></TitleF>
    <TitleE>Assessment of Seminal Lactoferrin Levels in Oligoasthenoterato-zoospermic Men with Varicocele</TitleE>
    <TitleLang_ID>2</TitleLang_ID>
    <ABSTRACTS>
        <ABSTRACT>
            <Language_ID>1</Language_ID>
            <CONTENT>140263</CONTENT>
        </ABSTRACT>
        <ABSTRACT>
            <Language_ID>2</Language_ID>
            <CONTENT>&lt;p&gt;Background: The association between varicocele and male infertility has always been a subject of ongoing debate. Lactoferrin (LF) belongs to the transferrin family with iron-binding properties and exhibits many beneficial biological properties. The purpose of the current study was to assess seminal levels of LF in infertile oligoasthenoteratozoospermic (OAT) men with varicocele.&lt;br /&gt;
Methods: Sixty-nine men were allocated into three groups; healthy fertile men (as controls) (n=20), infertile OAT men without varicocele (n=19), and infertile OAT men with varicocele (n=30). All men underwent history taking, genital examination, semen analysis, and determination levels of seminal LF by ELISA method. Statistical analysis was carried out using Kruskal-Wallis test followed by post-hoc analysis (Conover) for comparisons involving more than two groups, and the Mann-Whitney U test for comparisons between two groups. Spearman correlation test was used to assess the relationship between variables. The p&gt;0.05 was set as statistically significant.&#160;&lt;br /&gt;
Results: The median seminal LF level of the healthy fertile controls demonstrated significantly increased levels compared to both groups of infertile OAT men with or without varicocele (p&lt;0.000001). The median seminal LF level of the infertile OAT men with varicocele grade III demonstrated a significant decrease compared to infertile OAT men with grade II (p=0.0057). Collectively, seminal LF levels exhibited significant positive correlations with sperm concentration, total sperm motility, and normal sperm morphology.&lt;br /&gt;
Conclusion: LF can be an imperative seminal biomarker that decreases in infertile OAT men especially if associated with varicocele.&lt;/p&gt;</CONTENT>
        </ABSTRACT>
    </ABSTRACTS>
    <PAGES>
        <PAGE>
            <FPAGE>119</FPAGE>
            <TPAGE>126</TPAGE>
        </PAGE>
    </PAGES>
    <AUTHORS>
        <AUTHOR>
<Name>Mahmoud F</Name>
<MidName>MF</MidName>
<Family>Ghaly</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Andrology, Sexology and STIs, Faculty of Medicine, Cairo University</Organization>
</Organizations>
<Universities>
<University>Department of Andrology, Sexology and STIs, Faculty of Medicine, Cairo University</University>
</Universities>
<Countries>
<Country>Egypt</Country>
</Countries>
<EMAILS>
<Email>mahmoud.fawzy@kasralainy.edu.eg</Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Khadiga</Name>
<MidName>Kh</MidName>
<Family>Abougabal</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Clinical and Chemical Pathology, Faculty of Medicine, Beni-Suef University</Organization>
</Organizations>
<Universities>
<University>Department of Clinical and Chemical Pathology, Faculty of Medicine, Beni-Suef University</University>
</Universities>
<Countries>
<Country>Egypt</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Ayman A</Name>
<MidName>AA</MidName>
<Family>Allam</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Andrology, Sexology and STIs, Faculty of Medicine, Cairo University</Organization>
</Organizations>
<Universities>
<University>Department of Andrology, Sexology and STIs, Faculty of Medicine, Cairo University</University>
</Universities>
<Countries>
<Country>Egypt</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Ayad</Name>
<MidName>A</MidName>
<Family>Palani</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Basic Sciences, College of Medicine, University of Garmian</Organization>
</Organizations>
<Universities>
<University>Department of Basic Sciences, College of Medicine, University of Garmian</University>
</Universities>
<Countries>
<Country>Iraq</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Taymour</Name>
<MidName>T</MidName>
<Family>Mostafa</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Clinical Biochemistry, Zanko Central Laboratory</Organization>
</Organizations>
<Universities>
<University>Department of Clinical Biochemistry, Zanko Central Laboratory</University>
</Universities>
<Countries>
<Country>Iraq</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR>
    </AUTHORS>
    <KEYWORDS>
        <KEYWORD><KeyText>Male infertility</KeyText></KEYWORD><KEYWORD><KeyText>Lactoferrin</KeyText></KEYWORD><KEYWORD><KeyText>Seminal plasma</KeyText></KEYWORD><KEYWORD><KeyText>Oligoasthenoteratozoospermia (OAT)</KeyText></KEYWORD><KEYWORD><KeyText>Varicocele</KeyText></KEYWORD>
    </KEYWORDS>
    <PDFFileName>140263.pdf</PDFFileName>
    <REFRENCES>
        <REFRENCE>
            <REF>Zegers-Hochschild F, Adamson GD, Dyer S. The international glossary on infertility and fertility care. Fertil Steril. 2017;108(3):393-406.##Vander Borght M, Wyns C. Fertility and infertility: definition and epidemiology. Clin Biochem. 2018;62:2-10.##Zavattaro M, Ceruti C, Motta G, Allasia S, Marinelli L, Tagliabu M et al. Treating varicocele: Current knowledge and treatment options. J Endocrinol Invest. 2018;41(12):1365-75.##Clavijo RI, Carrasquillo R, Ramasamy R. Varicoceles: prevalence and pathogenesis in adult men. Fertil Steril. 2017;108(3):364-9.##Arya D, Balasinor N, Singh D. Varicocoele-associated male infertility: Cellular and molecular perspectives of pathophysiology. Andrology. 2022;10(8):1463-83.##Elahi M, Hojati V, Hashemitabar M, Afrough M, Mohammadpour Kargar H, Dastoorpoor M. Negative effect of varicocele on sperm mitochondrial dysfunction: a cross-sectional study. Int J Reprod Biomed. 2023;21(4):323-32.##Mostafa T, Anis T, Imam H, El-Nashar AR, Osman IA. Seminal reactive oxygen species-antioxidant relationship in fertile males with and without varicocele. Andrologia. 2009;41(2):125-9.##Damsgaard J, Joensen UN, Carlsen E, Erenpreiss J, Blomberg Jensen M, Matulevicius V et al. Varicocele is associated with impaired semen quality and reproductive hormone levels: a study of 7035 healthy young men from six European countries. Eur Urol. 2016;70(6):1019-29.##Jensen CFS, &#216;stergren P, Dupree JM, Ohl DA, S&#248;nksen J, Fode M. Varicocele and male infertility. Nat Rev Urol. 2017;14(9):523-33.##Lai TC, Roychoudhury S, Cho CL. Oxidative stress and varicocele-associated male infertility. Adv Exp Med Biol. 2022;1358:205-35.##Mazurier J, Spik G. Comparative study of the iron-binding properties of human transferrins. I. Complete and sequential iron saturation and desaturation of the lactotransferrin. Biochim Biophys Acta. 1980;629(2):399-408.##Kowalczyk P, Kaczyńska K, Kleczkowska P, Bukowska-Ośko I, Kramkowski K, Sulejczak D. The lactoferrin phenomenon-a miracle molecule. Molecules. 2022;27(9):2941.##Cao X, Ren Y, Lu Q, Wang K, Wu Y, Wang Y et al. Lactoferrin: A glycoprotein that plays an active role in human health. Front Nutr. 2023;9:1018336.##Masson P, Heremans J. Studies on lactoferrin, the iron-binding protein of secretions. Prot Biol Fluids. 1966;14:115-24.##Hekman A, Rumke P. The antigens of human seminal plasma. With special reference to lactoferrin as a spermatozoa-coating antigen. Ferti Steril. 1969;20(2):312-23.##Thaler CJ, Vanderpuye OA, McIntyre JA, Faulk WP. Lactoferrin binding molecules in human seminal plasma. Biol Reprod. 1990;43(4):712-7.##Martins HS, da Silva GC, Cortes SF, Paes FO, Martins Filho OA, Araujo M et al. Lactoferrin increases sperm membrane functionality of frozen equine semen. Reprod Domest Anim. 2018;53 (3):617-23.##Su J, Wang C, Song Y, Yang Y, Cao G. Effect of lactoferrin on ram sperm motility after cryopreservation. Anim Biosci. 2022;35(9):1351-9.##Zumoffen CM, Massa E, Caille AM, Munuce MJ, Ghersevich SA. Effects of lactoferrin, a protein present in the female reproductive tract, on parameters of human sperm capacitation and gamete interaction. Andrology. 2015;3(6):1068-75.##Hamada A, Sharma R, du Plessis SS, Willard B, Yadav SP, Sabanegh E et al. Two-dimensional differential in-gel electrophoresis-based proteomics of male gametes in relation to oxidative stress. Fertil Steril. 2013;99(5):1216-26.e2.##World Health Organization. WHO laboratory manual for the examination and processing of human semen. 6th ed. Switzerland: Geneva: WHO Press; 2010. 276 p.##Kim YS, Kim SK, Cho IC, Min SK. Efficacy of scrotal Doppler ultrasonography with the Valsalva maneuver, standing position, and resting-Valsalva ratio for varicocele diagnosis. Korean J Urol. 2015;56(2):144-9.##Sharma R, Gupta S, Agarwal A, Henkel R, Finelli R, Parekh N, et al. Relevance of leukocytospermia and semen culture and its true place in diagnosing and treating male infertility. World J Mens Health. 2022;40(2):191-207.##Park SY, Jeong AJ, Kim GY, Jo A, Lee JE, Leem SH, et al. Lactoferrin protects human mesenchymal stem cells from oxidative stress-induced senescence and apoptosis. J Microbiol Biotechnol. 2017;27(10):1877-84.##Ohradanova-Repic A, Praženicov&#225; R, Gebetsberger L, Moskalets T, Skrabana R, Cehlar O, et al. Time to kill and time to heal: the multifaceted role of lactoferrin and lactoferricin in host defense. Pharmaceutics. 2023;15(4):1056.##Mostafa T, Rashed LA, Osman I, Marawan M. Seminal plasma oxytocin and oxidative stress levels in infertile men with varicocele. Andrologia. 2015;47(2):209-13.##Mikhael NW, El-Refaie AM, Sabry JH, Akl EM, Habashy AY, Mostafa T. Assessment of seminal granulysin in infertile men with varicocele. Andrologia. 2018;50(8):e13066.##Abd El Rahman SH, Rashed LA, Akl EM, Mostafa T. Assessment of seminal YKL-40 in infertile men with varicocele. Andrologia. 2020;52(10):e13756.##Mostafa T, El-Taweel AEI, Rashed LA, Mohammed NAM, Akl EM. Assessment of seminal cystatin C levels in infertile men with varicocele: A preliminary study. Andrologia. 2022;54(1):e14278.##Ammar O, Tekeya O, Hannachi I, Sallem A, Haouas Z, Mehdi M. Increased Sperm DNA Fragmentation in infertile men with varicocele: relationship with apoptosis, seminal oxidative stress, and spermatic parameters. Reprod Sci. 2021;28(3):909-19.##Shah R, Agarwal A, Kavoussi P, Rambhatla A, Saleh R, Cannarella R, Harraz AM et al. Consensus and diversity in the management of varicocele for male infertility: Results of a global practice survey and comparison with guidelines and recommendations. World J Mens Health. 2023;41(1):164-97.##Dutta S, Majzoub A, Agarwal A. Oxidative stress and sperm function: A systematic review on evaluation and management. Arab J Urol. 2019;17(2):87-97.##He H, Chen X, Li X, Yang K, Li J, Shi H. Lactoferrin alleviates spermatogenesis dysfunction caused by bisphenol A and cadmium via ameliorating disordered autophagy, apoptosis and oxidative stress. Int J Biol Macromol. 2022;222(Pt A):1048-62.##Autiero M, Sansone G, Abrescia P. Relative ratios of lactoferrin, albumin, and acid phosphatase seminal levels as sperm quality markers in fertile and infertile men. J Androl. 1991;12(3):191-200.##Buckett W, Luckas M, Gazvani M, Aird I, Lewis D. Seminal plasma lactoferrin concentrations in normal and abnormal semen samples. J Androl. 1997;18(3):302-4.##Alkan İ, Y&#252;ksel M, Canat HL, Atalay HA, Can O, &#214;zveri H et al. Superoxide anion production by the spermatozoa of men with varicocele: relationship with varicocele grade and semen parameters. World J Mens Health. 2018;36(3):255-62.##Mostafa T, Abougabal K, Mintziori G, Nabil N, Adel M, AboSief AF. Seminal L-carnitine in infertile oligoasthenoteratozoospermic men with varicocele. J Reprod Infertil. 2022;23(1):26-32.##Ashrafzade AM, Sadighi Gilani MA, Topraggaleh TR, Khojasteh M, Sepidarkish M, Borjian Boroujeni P et al. Oxidative stress-related miRNAs in spermatozoa may reveal the severity of damage in grade III varicocele. Andrologia. 2020;52(9):e13598.##Azab SS, Mostafa T, Abougabal KM, Tohamy AA, Nabil N. Assessment of seminal calcium and magnesium levels in infertile men with varicocele before and after varicocelectomy. Andrology. 2021;9(6):1853-8.##Steiner AZ, Hansen KR, Barnhart KT, Cedars MI, Legro RS, Diamond MP et al. Reproductive Medicine Network. The effect of antioxidants on male factor infertility: the males, antioxidants, and infertility (MOXI) randomized clinical trial. Fertil Steril. 2020;113(3):552-60.e3.##Agarwal A, Finelli R, Selvam MKP, Leisegang K, Majzoub A, Tadros N et al. A Global survey of reproductive specialists to determine the clinical utility of oxidative stress testing and antioxidant use in male infertility. World J Mens Health. 2021;39(3):470-88.##Knudtson JF, Sun F, Coward RM, Hansen KR, Barnhart KT, Smith J et al. The relationship of plasma antioxidant levels to semen parameters: the males, antioxidants, and infertility (MOXI) randomized clinical trial. J Assist Reprod Genet. 2021;38(11):3005-13.##Martins HS, Souza MR, Penna CF, da Silva GC, C&#244;rtes SF, Stahlberg R et al. Milk, caseinate and lactoferrin addition to equine semen cooling extenders. Andrologia. 2016;48(9):862-8.##Martins HS, da Silva GC, Cortes SF, Paes FO, Martins Filho OA, Araujo M et al. Lactoferrin increases sperm membrane functionality of frozen equine semen. Reprod Domest Anim. 2018;53(3):617-23.##Massa E, Gola A, Moriconi M, Lo Celso A, Madariaga MJ, Pelusa F et al. Lactoferrin affects in vitro and in vivo fertilization and implantation in rats. Biometals. 2023;36(3):575-85.##Abdelbaki SA, Sabry JH, Al-Adl AM, Sabry HH. The impact of coexisting sperm DNA fragmentation and seminal oxidative stress on the outcome of varicocelectomy in infertile patients: A prospective controlled study. Arab J Urol. 2017;15(2):131-9.##Cannarella R, Shah R, Saleh R, Boitrelle F, Hamoda TAA, Singh R, et al. Effects of varicocele repair on sperm DNA fragmentation and seminal malondialdehyde levels in infertile men with clinical varicocele: a systematic review and meta-analysis. World J Mens Health. 2024;42(2):321-37.##</REF>
        </REFRENCE>
    </REFRENCES>
</ARTICLE>

<ARTICLE>
    <TitleF></TitleF>
    <TitleE>From High Risk to Hope: A Case Report of Live Birth from Cesarean Scar Pregnancy with Placenta Percreta</TitleE>
    <TitleLang_ID>2</TitleLang_ID>
    <ABSTRACTS>
        <ABSTRACT>
            <Language_ID>1</Language_ID>
            <CONTENT>140268</CONTENT>
        </ABSTRACT>
        <ABSTRACT>
            <Language_ID>2</Language_ID>
            <CONTENT>&lt;p&gt;Background: Cesarean scar pregnancy (CSP) is a rare yet serious condition involving implantation of the gestational sac at the site of a prior cesarean delivery. The management becomes increasingly complex with the addition of placenta percreta. In this paper, a case of CSP complicated by placenta percreta was reported which was successfully managed through a multidisciplinary approach.&lt;br /&gt;
Case Presentation: A 35-year-old G4P3 woman was diagnosed with CSP at 6 weeks of gestation. Despite counseling on the risks, she opted to continue the pregnancy. Placenta percreta was diagnosed at 18 weeks. A multidisciplinary team monitored the pregnancy closely, leading to the delivery of a healthy infant at 32 weeks via cesarean delivery and subsequent hysterectomy.&lt;br /&gt;
Conclusion: Multidisciplinary management and close follow-up are crucial in managing high-risk CSP cases, especially those complicated by abnormal placentation.&lt;/p&gt;</CONTENT>
        </ABSTRACT>
    </ABSTRACTS>
    <PAGES>
        <PAGE>
            <FPAGE>126</FPAGE>
            <TPAGE>131</TPAGE>
        </PAGE>
    </PAGES>
    <AUTHORS>
        <AUTHOR>
<Name>Nona</Name>
<MidName>N</MidName>
<Family>Sabeti</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Obstetrics and Gynecology, Faculty of Medicine, Mashhad University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Department of Obstetrics and Gynecology, Faculty of Medicine, Mashhad University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email>ninosb2000@gmail.com</Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Houra</Name>
<MidName>H</MidName>
<Family>Mousavi Vahed</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Associate Professor of obstetrics &amp;amp; Gynecology, Faculty of Medicine, Mashhad University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Associate Professor of obstetrics &amp; Gynecology, Faculty of Medicine, Mashhad University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Azam</Name>
<MidName>A</MidName>
<Family>Pourhoseini</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Associate Professor of obstetrics &amp;amp; Gynecology, Faculty of Medicine, Mashhad University of Medical Sciences</Organization>
</Organizations>
<Universities>
<University>Associate Professor of obstetrics &amp; Gynecology, Faculty of Medicine, Mashhad University of Medical Sciences</University>
</Universities>
<Countries>
<Country>Iran</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR>
    </AUTHORS>
    <KEYWORDS>
        <KEYWORD><KeyText>Abnormal placentation</KeyText></KEYWORD><KEYWORD><KeyText>Cesarean scar pregnancy</KeyText></KEYWORD><KEYWORD><KeyText>Hysterectomy</KeyText></KEYWORD><KEYWORD><KeyText>Live birth</KeyText></KEYWORD><KEYWORD><KeyText>Placenta percreta</KeyText></KEYWORD>
    </KEYWORDS>
    <PDFFileName>140268.pdf</PDFFileName>
    <REFRENCES>
        <REFRENCE>
            <REF>Seow KM, Huang LW, Lin YH, Lin MY, Tsai YL, Hwang JL. Cesarean scar pregnancy: issues in management. Ultrasound Obstet Gynecol. 2004;23(3):247-53.##Valasoulis G, Magaliou I, Koufidis D, Garas A, Daponte A. Caesarean scar pregnancy: a case report and a literature review. Medicina (Kaunas). 2022;58(6):740.##Kutlesic R, Kutlesic M, Vukomanovic P, Stefanovic M, Mostic-Stanisic D. Cesarean scar pregnancy successfully managed to term: when the patient is determined to keep the pregnancy. Medicina (Kaunas). 2020;56(10):496.##Timor-Tritsch IE, Monteagudo A, Santos R, Tsymbal T, Pineda G, Arslan AA. The diagnosis, treatment, and follow-up of cesarean scar pregnancy. Am J Obstet Gynecol. 2012;207(1):44.e1-13.##Maymon R, Halperin R, Mendlovic S, Schneider D, Vaknin Z, Herman A, et al. Ectopic pregnancies in Caesarean section scars: the 8 year experience of one medical centre. Hum Reprod. 2004;19(2):278-84.##Huang J, Phillips C, Moshiri M. Scarred for life: a review of cesarean section scar pregnancy and potential pitfalls in diagnosis. Abdom Radiol (NY). 2023;48(8):2672-83.##Wang CB, Tseng CJ. Primary evacuation therapy for Cesarean scar pregnancy: three new cases and review. Ultrasound Obstet Gynecol. 2006;27(2):222-6.##Jurkovic D, Wilkinson H. Diagnosis and management of ectopic pregnancy. BMJ. 2011;342:d3397.##Zhang Y, Zhang Z, Liu X, Zhang L, Hong F, Lu M. Risk factors for massive hemorrhage during the treatment of cesarean scar pregnancy: a systematic review and meta-analysis. Arch Gynecol Obstet. 2021;303(2):321-8.##Jurkovic D, Hillaby K, Woelfer B, Lawrence A, Salim R, Elson CJ. First-trimester diagnosis and management of pregnancies implanted into the lower uterine segment Cesarean section scar. Ultrasound Obstet Gynecol. 2003;21(3):220-7.##Suzuki N, Kyozuka H, Fukuda T, Murata T, Kanno A, Yasuda S, et al. Late-diagnosed cesarean scar pregnancy resulting in unexpected placenta accreta spectrum necessitating hysterectomy. Fukushima J Med Sci. 2020;66(3):156-9.##Jayaram PM, Okunoye GO, Konje J. Caesarean scar ectopic pregnancy: diagnostic challenges and management options. Obstet Gynaecol. 2017;19(1):13-20.##Malhotra N, Noor N, Bansal P, Sharma K. Successful management of caesarean scar ectopic pregnancies: a report of five cases. J Reprod Infertil. 2021;22(3):220-4.##Lin R, DiCenzo N, Rosen T. Cesarean scar ectopic pregnancy: nuances in diagnosis and treatment. Fertil Steril. 2023;120(3 Pt 2):563-72.##Shiber Y, Maymon R, Gal-Kochav M, Kugler N, Pekar-Zlotin M, Smorgick N, et al. Caesarean scar pregnancy: is there a light in the end of the tunnel? Arch Gynecol Obstet. 2023;307(4):1057-64.##Rotas MA, Haberman S, Levgur M. Cesarean Scar Ectopic Pregnancies: Etiology, Diagnosis, and Management. Obstet Gynecol. 2006;107(6):1373-81.##Sun H, Wang J, Fu P, Zhou T, Liu R. Systematic evaluation of the efficacy of treatments for cesarean scar pregnancy. Reprod Biol Endocrinol. 2024;22(1):84.##Cal&#236; G, Timor-Tritsch IE, Palacios-Jaraquemada J, Monteaugudo A, Buca D, Forlani F, et al. Outcome of cesarean scar pregnancy managed expectantly: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2018;51(2):169-75.##Silva B, Viana Pinto P, Costa MA. Cesarean scar pregnancy: a systematic review on expectant management. Eur J Obstet Gynecol Reprod Biol. 2023;288:36-43.##Timor-Tritsch IE, Khatib N, Monteagudo A, Ramos J, Berg R, Kov&#225;cs S. Cesarean scar pregnancies: experience of 60 cases. J Ultrasound Med. 2015;34(4):601-10.##Cal&#236; G, Timor-Tritsch IE, Palacios-Jaraquemada J, Monteaugudo A, Buca D, Forlani F, et al. Outcome of cesarean scar pregnancy managed expectantly: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2018;51(2):169-75.##Birch Petersen K, Hoffmann E, Rifbjerg Larsen C, Svarre Nielsen H. Cesarean scar pregnancy: a systematic review of treatment studies. Fertil Steril. 2016;105(4):958-67.##</REF>
        </REFRENCE>
    </REFRENCES>
</ARTICLE>

<ARTICLE>
    <TitleF></TitleF>
    <TitleE>Accessory Cavitated Uterine Mass: A Diagnostic Dilemma Illustrated by Three Case Reports</TitleE>
    <TitleLang_ID>2</TitleLang_ID>
    <ABSTRACTS>
        <ABSTRACT>
            <Language_ID>1</Language_ID>
            <CONTENT>140269</CONTENT>
        </ABSTRACT>
        <ABSTRACT>
            <Language_ID>2</Language_ID>
            <CONTENT>&lt;p&gt;Background: Accessory cavitated uterine mass (ACUM) is a rare, unclassified M&#252;llerian anomaly characterized by distinct imaging features. It is typically lo-cated within the uterus, close to the round ligament, and has a uterus-like struc-tural arrangement. The patient may present with pelvic pain or dysmenorrhea. Most of these cases are misdiagnosed because of a lack of awareness about this unusual entity.&#160;&lt;br /&gt;
Case Presentation: Three cases of ACUM in young patients who experienced prolonged symptoms and had incomplete family structures were reported in this paper. Initially, two of these cases were misdiagnosed during ultrasound exami-nations (USG). The subsequent magnetic resonance imaging (MRI) revealed characteristic imaging features consistent with ACUM, which provided signifi-cant psychological relief to both the patients and their families. Two patients re-ceived hormonal therapy, both of whom were unmarried. The third patient, however, indicated a wish to conceive and was therefore initiated on analgesics. All three patients chose to forgo surgical intervention, opting instead for medi-cal management despite its limited success in alleviating their symptoms. This decision was made to minimize obstetric risks associated with surgical interven-tions in potential future pregnancies.&lt;br /&gt;
Conclusion: Laparoscopy or open surgery is the mainstay treatment for a per-manent relief from the symptoms. However, surgical treatment should be of-fered with caution as no data are available in medical literature regarding the ef-fect of surgically induced myometrial scarring on patients’ reproductive out-comes. Since most of these patients were young and nulligravida, the therapy had to be personalized in accordance with the patient’s preference and family status.&lt;/p&gt;</CONTENT>
        </ABSTRACT>
    </ABSTRACTS>
    <PAGES>
        <PAGE>
            <FPAGE>131</FPAGE>
            <TPAGE>138</TPAGE>
        </PAGE>
    </PAGES>
    <AUTHORS>
        <AUTHOR>
<Name>Shruti</Name>
<MidName>Sh</MidName>
<Family>Thakur</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Radiodiagnosis, Indira Gandhi Medical College and Hospital (IGMC)</Organization>
</Organizations>
<Universities>
<University>Department of Radiodiagnosis, Indira Gandhi Medical College and Hospital (IGMC)</University>
</Universities>
<Countries>
<Country>India</Country>
</Countries>
<EMAILS>
<Email>tshruti878@yahoo.in</Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Sanjay</Name>
<MidName>S</MidName>
<Family>Kumar</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Radiodiagnosis, Indira Gandhi Medical College and Hospital (IGMC)</Organization>
</Organizations>
<Universities>
<University>Department of Radiodiagnosis, Indira Gandhi Medical College and Hospital (IGMC)</University>
</Universities>
<Countries>
<Country>India</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Sushma</Name>
<MidName>S</MidName>
<Family>Makhaik</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Radiodiagnosis, Indira Gandhi Medical College and Hospital (IGMC)</Organization>
</Organizations>
<Universities>
<University>Department of Radiodiagnosis, Indira Gandhi Medical College and Hospital (IGMC)</University>
</Universities>
<Countries>
<Country>India</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Neeti</Name>
<MidName>N</MidName>
<Family>Aggarwal</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Radiodiagnosis, Indira Gandhi Medical College and Hospital (IGMC)</Organization>
</Organizations>
<Universities>
<University>Department of Radiodiagnosis, Indira Gandhi Medical College and Hospital (IGMC)</University>
</Universities>
<Countries>
<Country>India</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR>
    </AUTHORS>
    <KEYWORDS>
        <KEYWORD><KeyText>Analgesics</KeyText></KEYWORD><KEYWORD><KeyText>Conservative treatment</KeyText></KEYWORD><KEYWORD><KeyText>Dysmenorrhea</KeyText></KEYWORD><KEYWORD><KeyText>Hormones</KeyText></KEYWORD><KEYWORD><KeyText>Laparascopy</KeyText></KEYWORD><KEYWORD><KeyText>Magnetic resonance imaging</KeyText></KEYWORD><KEYWORD><KeyText>Pelvic pain</KeyText></KEYWORD><KEYWORD><KeyText>Pregnancy</KeyText></KEYWORD><KEYWORD><KeyText>Uterus</KeyText></KEYWORD>
    </KEYWORDS>
    <PDFFileName>140269.pdf</PDFFileName>
    <REFRENCES>
        <REFRENCE>
            <REF>Aci&#233;n P, Aci&#233;n M, Fern&#225;ndez F, Jos&#233; Mayol M, Aranda I. The cavitated accessory uterine mass: a Mullerian anomaly in women with an otherwise normal uterus. Obstet Gynecol. 2010;116(5):1101-9.##Betzler N, Brunes M, Anfelter P, Wedlund L, Persson J, Epstein E. Sonografic features of accessory cavitated uterine mass (ACUM) successfully treated with robotic assisted laparoscopic surgery-a case report. Clin Obstet Gynecol Reprod Med. 2019;5(6):1-4.##Zajaczkowska W, Kapczuk K. Accessory cavitated uterine mass (ACUM) as a miniature uterine anomaly causing severe lateralized dysmenorrhea: case series. Ginekol Pol. 2023;94(11):907-12.##Dekkiche S, Dubruc E, Kanbar M, Feki A, Mueller M, Meuwly JY, et al. Accessory and cavitated uterine masses: a case series and review of the literature. Front Reprod Health. 2023;5:1197931.##Aci&#233;n P, del Campo FS, Mayol MJ, Aci&#233;n M. The female gubernaculum: role in the embryology and development of the genital tract and in the possible genesis of malformations. Eur J Obstet Gynecol Reprod Biol. 2011;159(2):426-32.##Jain N, Verma R. Imaging diagnosis of accessory and cavitated uterine mass, a rare mullerian anomaly. Indian J Radiol Imaging. 2014;24(2):178-81.##Strug M, Christmas A, Schoonover A, Romero VC, Cordoba M, Leary E, et al. Impact of an accessory cavitated uterine mass on fertility: case presentation and review of the literature. F S Rep. 2023;4(4):402-9.##Deng F, Liu K, Huang Y, Chen Q, Wang L, Xiao X, et al. Successful treatment of a rare giant accessory cavitated uterine mass: a case report. J Int Med Res. 2024;52(5):3000605241252238.##Putta T, John R, Simon B, Sathyakumar K, Chandramohan A, Eapen A. Imaging manifestations of accessory cavitated uterine mass-a rare mullerian anomaly. Indian J Radiol Imaging. 2021;31(3):545-50.##Hu Q, Guo C, Chen Q, Zhang W, Wang H, Wei W. ACUM, an easily underdiagnosed cause of dysmenorrhea-a case report. Front Med (Lausanne). 2024;11:1308299.##11.	HaiJing He, XuZhi Liang, Jiangtao Fan et al. Accessory and cavitated uterine mass (ACUM) in an 18-year-old woman: a case report and literature review, 04 January 2022, PREPRINT (Version 1) available at Research Square [https://doi.org/10. 21203/rs.3.rs-1120568/v1].##Mondal R, Bhave P. Accessory cavitated uterine malformation (ACUM): a hidden face of dysmenorrhea. Indian J Obstet Gynecol Res. 2022;9(4):452-6.##Mahey R, Cheluvaraju R, Kumari S, Kachhawa G, Kumari A, Rajput M, et al. Robert&#39;s uterus versus Juvenile cystic adenomyoma–diagnostic and therapeutic challenges–case report and review of literature. J Hum Reprod Sci. 2023;16(1):79-86.##Takeuchi H, Kitade M, Kikuchi I, Kumakiri J, Kuroda K, Jinushi M. Diagnosis, laparoscopic management, and histopathologic findings of juvenile cystic adenomyoma: a review of nine cases. Fertil Steril. 2010;94(3):862-8.##Murase E, Siegelman ES, Outwater EK, Perez-Jaffe LA, Tureck RW. Uterine leiomyomas: histopathologic features, MR imaging findings, differential diagnosis, and treatment. Radiographics. 1999;19(5):1179-97.##Kriplani A, Mahey R, Agarwal N, Bhatla N, Yadav R, Singh MK. Laparoscopic management of juvenile cystic adenomyoma: four cases. J Minim Invasive Gynecol. 2011;18(3):343-8.##Timmerman S, Stubbe L, Van den Bosch T, Van Schoubroeck D, Tellum T, Froyman W. Accessory cavitated uterine malformation (ACUM): a scoping review. Acta Obstet Gynecol Scand. 2024;103(6):1036-45.##</REF>
        </REFRENCE>
    </REFRENCES>
</ARTICLE>

<ARTICLE>
    <TitleF></TitleF>
    <TitleE>A Case Report of a 20-Week Unruptured Tubal Ectopic Pregnancy: An Exceptionally Rare Clinical Entity</TitleE>
    <TitleLang_ID>2</TitleLang_ID>
    <ABSTRACTS>
        <ABSTRACT>
            <Language_ID>1</Language_ID>
            <CONTENT>140265</CONTENT>
        </ABSTRACT>
        <ABSTRACT>
            <Language_ID>2</Language_ID>
            <CONTENT>&lt;p&gt;Background: Ectopic pregnancy remains one of the most common causes of pregnancy-related deaths in the first trimester. About 2.4% of ectopic pregnancies occur in the interstitial part of the fallopian tubes. Given the nonspecific symptoms and the increased risk of hemorrhage associated with interstitial pregnancy localization, early diagnosis is crucial and should be based not only on clinical presentation but also on adjunctive diagnostic modalities. Early diagnosis leads to better treatment-related outcomes. Tubal ectopic pregnancies rarely progress into the second trimester and are typically diagnosed during the first trimester.&#160;&lt;br /&gt;
Case Presentation: A 25-year-old primigravida at 20 weeks of gestation was initially diagnosed with a single live intrauterine pregnancy but presented with hypovolemic shock and was intraoperatively found to have an unruptured ectopic pregnancy. Postoperatively, the patient remained hemodynamically stable and was discharged on the fifth day. To date, the highest gestational age reported for a tubal ectopic pregnancy is 14 weeks.&lt;br /&gt;
Conclusion: Ectopic pregnancies should be diagnosed in the first trimester via expert ultrasound. In this case, delayed second-trimester ultrasound in a low-income patient led to missed diagnosis. Clinical judgment must guide antenatal care, and surgery should not be delayed despite an unidentified source of hemoperitoneum.&lt;/p&gt;</CONTENT>
        </ABSTRACT>
    </ABSTRACTS>
    <PAGES>
        <PAGE>
            <FPAGE>138</FPAGE>
            <TPAGE>142</TPAGE>
        </PAGE>
    </PAGES>
    <AUTHORS>
        <AUTHOR>
<Name>Meenakshi</Name>
<MidName>M</MidName>
<Family>Ruhil</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Obstetrics and Gynecology, Government Medical College and Hospital (GMCH)</Organization>
</Organizations>
<Universities>
<University>Department of Obstetrics and Gynecology, Government Medical College and Hospital (GMCH)</University>
</Universities>
<Countries>
<Country>India</Country>
</Countries>
<EMAILS>
<Email>ruhilmeenakshi@gmail.com</Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Anil</Name>
<MidName>A</MidName>
<Family>Humane</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Obstetrics and Gynecology, Government Medical College and Hospital (GMCH)</Organization>
</Organizations>
<Universities>
<University>Department of Obstetrics and Gynecology, Government Medical College and Hospital (GMCH)</University>
</Universities>
<Countries>
<Country>India</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Sarika</Name>
<MidName>S</MidName>
<Family>Thakare</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Obstetrics and Gynecology, Government Medical College and Hospital (GMCH)</Organization>
</Organizations>
<Universities>
<University>Department of Obstetrics and Gynecology, Government Medical College and Hospital (GMCH)</University>
</Universities>
<Countries>
<Country>India</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR>
    </AUTHORS>
    <KEYWORDS>
        <KEYWORD><KeyText>Ectopic pregnancy</KeyText></KEYWORD><KEYWORD><KeyText>Methotrexate</KeyText></KEYWORD><KEYWORD><KeyText>Ultrasonography</KeyText></KEYWORD>
    </KEYWORDS>
    <PDFFileName>140265.pdf</PDFFileName>
    <REFRENCES>
        <REFRENCE>
            <REF>Panelli DM, Phillips CH, Brady PC. Incidence, diagnosis and management of tubal and non-tubal ectopic pregnancies: a review. Fertil Res Pract. 2015;1:15.##Taran FA, Kagan KO, H&#252;bner M, Hoopmann M, Wallwiener D, Brucker S. The diagnosis and treatment of ectopic pregnancy. Dtsch Arztebl Int. 2015;112(41):693‐703.##Elmoheen A, Salem W, Eltawagny M, Elmoheen R, Bashir K. The largest tubal pregnancy: 14th week. Case Rep Obstet Gynecol. 2020;2020:4728730.##Shao R. Understanding the mechanisms of human tubal ectopic pregnancies: new evidence from knockout mouse models. Hum Reprod. 2010;25(3):584-7.##Kirk E, Bourne T. Ectopic pregnancy. Obstet Gynecol Reprod Med. 2011;21(7):207-11.##Nkwabong E, Tincho EF. A case of a 26-week ampullary pregnancy mimicking intrauterine fetal death. Anatol J Obstet Gynecol. 2012;1(1):1-3.##Bouyer J, Coste J, Fernandez H, Pouly JL, Job-Spira N. Sites of ectopic pregnancy: a 10-year population-based study of 1800 cases. Hum Reprod. 2002;17(12):3224-30.##Committee on practice bulletins—gynecology. ACOG practice bulletin No. 191: tubal ectopic pregnancy. Obstet Gynecol. 2018;131(2):e65-e77.##Samura TL, Vikins A, Hendessi P. Laparoscopic resection of interstitial ectopic pregnancy with placenta percreta. J Minim Invasive Gynecol. 2016;23:S147.##Gauvin C, Amberger M, Louie K, Argeros O. Previously asymptomatic ruptured tubal ectopic pregnancy at over 10 weeks&#39; gestation: two case reports. Case Rep Womens Health. 2018;21:e00089.##Kim M, Hiramatsu K, Fukui K, Amemiya K. Unexpected tubal pregnancy at 13 weeks’ gestation that was treated with laparoscopic surgery under massive hemoperitoneum. Gynecol Minim Invasive Ther. 2019;8(1):30-2.##</REF>
        </REFRENCE>
    </REFRENCES>
</ARTICLE>

<ARTICLE>
    <TitleF></TitleF>
    <TitleE>Effects of Specific Antivenom on Vital and Reproductive Organs in Male and Female Pups: Pathological and Immunohistochemical Findings in Pregnant Rats Inoculated with Androctonus crassicauda Venom During Organogenesis</TitleE>
    <TitleLang_ID>2</TitleLang_ID>
    <ABSTRACTS>
        <ABSTRACT>
            <Language_ID>1</Language_ID>
            <CONTENT>140249</CONTENT>
        </ABSTRACT>
        <ABSTRACT>
            <Language_ID>2</Language_ID>
            <CONTENT>&lt;p&gt;Background: The purpose of the current study was to reveal how the scorpion venom of Androctonus crassicauda has a damaging effect on the vital and reproductive organs of the offspring and how specific antivenom administration reverses the damages that occur during intrauterine organogenesis.&lt;br /&gt;
Methods: Twelve pregnant Wistar albino rats were randomly assigned into two groups: antivenom (AVG) and control healthy (C) groups. For envenomization, a venom solution at the dose of 1 &lt;em&gt;ml/kg&lt;/em&gt; body weight was injected subcutaneously into the AVG group of rats between days 7 and 13 of pregnancy. Then, antivenom serum was administered subcutaneously at a total sublethal dose of 1 ml daily. At the end of the 21st day of pregnancy, ovariohysterectomy was performed on all dams and all pups were removed. Six male and female pups from both the AVG and control groups were selected and. After histopathology, inducible nitric oxide synthase (iNOS), mitogen-activated protein (MAP), mammalian target of rapamycin (mTOR), G protein-coupled receptor (GPCR), C-X-C motif chemokine ligand 12 (CXCL12), and cannabinoid receptor 1 (CB1) expressions were evaluated.&lt;br /&gt;
Results: Based on the findings, it was shown that both genders exhibited increasing expressions parallel to histopathological changes, despite the stabile expressions of iNOS. However, CB1 expression in all examined organs including kidney, lung, uterus, and testicular tissues could not be adequately elevated to provide an effective cellular protection.&lt;br /&gt;
Conclusion: Functional reproductive organs have a greater capacity for self-pro-tection. It can be concluded that the efficacy of specific antivenom applications on the organ development of offspring following scorpion stings in pregnant subjects is significant.&lt;/p&gt;</CONTENT>
        </ABSTRACT>
    </ABSTRACTS>
    <PAGES>
        <PAGE>
            <FPAGE>272</FPAGE>
            <TPAGE>284</TPAGE>
        </PAGE>
    </PAGES>
    <AUTHORS>
        <AUTHOR>
<Name>Mehmet</Name>
<MidName>ME</MidName>
<Family>Alcigir</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Pathology, Faculty of Veterinary Medicine, Kirikkale University</Organization>
</Organizations>
<Universities>
<University>Department of Pathology, Faculty of Veterinary Medicine, Kirikkale University</University>
</Universities>
<Countries>
<Country>Turkey</Country>
</Countries>
<EMAILS>
<Email>erayalcigir@gmail.com, erayalcigir@kku.edu.tr</Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Ozcan</Name>
<MidName>O</MidName>
<Family>Ozkan</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Biology, Faculty of Science, Cankiri Karatekin University</Organization>
</Organizations>
<Universities>
<University>Department of Biology, Faculty of Science, Cankiri Karatekin University</University>
</Universities>
<Countries>
<Country>Turkey</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Merve</Name>
<MidName>MB</MidName>
<Family>Turkmen</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Department of Pathology, Faculty of Veterinary Medicine, Kirikkale University</Organization>
</Organizations>
<Universities>
<University>Department of Pathology, Faculty of Veterinary Medicine, Kirikkale University</University>
</Universities>
<Countries>
<Country>Turkey</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR><AUTHOR>
<Name>Murside</Name>
<MidName>MA</MidName>
<Family>Demirel</Family>
<NameE></NameE>
<MidNameE></MidNameE>
<FamilyE></FamilyE>
<Organizations>
<Organization>Laboratory Animals Care and Research Unit, Department of Pharmacology, Faculty of Pharmacy, Gazi University</Organization>
</Organizations>
<Universities>
<University>Laboratory Animals Care and Research Unit, Department of Pharmacology, Faculty of Pharmacy, Gazi University</University>
</Universities>
<Countries>
<Country>Turkey</Country>
</Countries>
<EMAILS>
<Email></Email>
</EMAILS>
</AUTHOR>
    </AUTHORS>
    <KEYWORDS>
        <KEYWORD><KeyText>Histopathology</KeyText></KEYWORD><KEYWORD><KeyText>Immunohistochemistry</KeyText></KEYWORD><KEYWORD><KeyText>Rat pups</KeyText></KEYWORD><KEYWORD><KeyText>Scorpion venom</KeyText></KEYWORD><KEYWORD><KeyText>Serum</KeyText></KEYWORD>
    </KEYWORDS>
    <PDFFileName>140249.pdf</PDFFileName>
    <REFRENCES>
        <REFRENCE>
            <REF>Petricevich VL. Scorpion venom and the inflammatory response. Mediators Inflamm. 2010;2010:903295.##Garc&#237;a-Guerreroa IA, C&#225;rcamo-Noriegaa E, G&#243;mez-Lagunas F, Gonz&#225;lez-Santill&#225;na E, Zamudio FZ, Gurrola GB, et al. Biochemical characterization of the venom from the Mexican scorpion Centruroides ornatus, a dangerous species to humans. Toxicon. 2020;173:27-38.##Al-Ramahi HM, Al-Hasnawi MH. Diagnostic and epidemiologic study of fat tail scorpion (Androctonus crassicuada) in mid-Euphrates Region Iraq. J Kerbala Univ. 2012;10(1):263-69.##Azzam NN. The protective effects and ameliorative potency of the haemolymph from the Saudi scorpion Androctonus crassicauda against the oxidative stress induced by its crude venom: a pharmacological study. J Biosci App Res. 2018;4(3):218-59.##Najafian M, Ghorbani A, Zargar M, Baradaran M, Baradaran, N. Scorpion stings in pregnancy: an analysis of outcomes in 66 envenomed pregnant patients in Iran. J Venom Anim Toxins Incl Trop Dis. 2020;26:e20190039.##Ben Nasr H, Hammami S, Mion G, Sahnoun Z, Chouaiekh F, Rebai T, et al. [Effects of Buthus occitanus tunetanus envenomation on an experimental murine model of gestation]. C R Biol. 2007;330(12):890-6. French.##Rutledge JC. Developmental toxicity induced during early stages of mammalian embryogenesis. Mutat Res. 1997;396(1-2):113-27.##Nasr H, Badraoui R, Serria H, Jamoussi K, Zeghal K. Embryotoxicity following repetitive maternal exposure to scorpion venom. J Venom Anim Toxins Incl Trop Dis. 2011;18:317-24.##Hmed BN, Riadh B, Serria H, Kamel J, Khaled Z. Embryotoxicity following repetitive maternal exposure to scorpion venom. J Venom Anim Toxins Incl Trop Dis. 201218(3):317-24.##Bar&#227;o AAS, Bellot RG, Dorce VA. Developmental effects of Tityus serrulatus scorpion venom on the rat offspring. Brain Res Bull. 2008;76(5):499-504.##Bar&#227;o AAS, Nencioni ALA, Coronado VA. Embryotoxic effects of maternal exposure to Tityus serrulatus scorpion venom. J Venom Anim Toxins Incl Trop Dis. 2008;14(2):322-37.##Ismail M. The scorpion envenoming syndrome. Toxicon. 1995;33(7):825-58.##Meki AR, Hasan HA, El-Deen ZM, Bakkar S. Dysregulation of apoptosis in scorpion envenomed children: its reflection on their outcome. Toxicon. 2003;42(3):229-37.##Nishisaka F, Sohen S, Fukuoka H, Okamoto Y, Matukawa M, Fukuda K, et al. Interleukin-4 reversed the interleukin-1-inhibited proteoglycan synthesis through the inhibition of NO release: a possible involvement of intracellular calcium ion. Pathophysiology. 2001;7(4):289-93.##Boveris A, Navarro A. Brain mitochondrial dysfunction in aging, IUBMB Life. 2008;60(5):308-14.##Kalam SR, Singh A, Mani J, Patel FN, Pandey A. Antioxidants: elixir of life. Int Multidiscip Res J. 2012;2(1):18-34.##Moustafa SR. Association of superoxide dismutase, glutathione peroxidase, catalse, and xanthine oxidase with incidence of bladder cancer. Cancer Res. 2015;3(2):17-27.##Dewan SK. Microwave effect in organic reactions. Indian J Chem. 2006;45(B):2337-40.##Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity. 2000;12(2):121-7.##Dorsam RT, Gutkind JS. G-protein-coupled receptors and cancer. Nat Rev Cancer. 2007;7(2):79-94.##Spiegelberg BD, Hamm HE. Roles of G-protein-coupledreceptorsignaling in cancerbiology and gene transcription. Curr Opin Genet Dev. 2007;17(1):40-4.##Azizian M, Mahdipour E, Mirhafez SR, Shoeibi S, Nematy M, Esmaily H, et al. Cytokine profiles in overweight and obese subjects and normal weight individuals matched for age and gender. Ann Clin Biochem. 2016;53(6):663-8.##Howlett AC, Blume LC, Dalton GD. CB(1) cannabinoid receptors and their associated proteins. Curr Med Chem. 2010;17(14):1382-93.##Hu X, Han W, Li L. Targeting the weak point of cancer by induction of necroptosis. Autophagy. 2007;3(5):490-2.##Benjamin D, Colombi M, Moroni C, Hall MN. Rapamycin passes the torch: a new generation of mTOR inhibitors. Nat Rev Drug Discov. 2011;10(11):868-80.##Kankonkar RC, Kulkurni DG, Hulikavi CB. Preparation of a potent anti-scorpion-venom-serum against the venom of red scorpion (Buthus tamalus). J Postgrad Med. 1998;44(4):85-92.##Chippaux JP, Goyffon M. Epidemiology of scorpionism: a global appraisal. Acta Trop. 2008;107(2):71-9.##Khatony A, Abd A, Fatahpour T, Towhid F. The epidemiology of scorpion stings in tropical areas of Kermanshah province. Iran, during 2008 and 2009. J Venom Anim Toxins Incl Trop Dis. 2015;21:45.##Queiroz AM, Sampaio VS, Mendon&#231;a I, F&#233; NF, Sachett J, Ferrera LC, et al. Severity of scorpion stings in the western Brazilian amazon: a case-control study. PLoS One. 2015;10(6):e0128819.##Ismail M, Abd-Elsalam MA, Al-Ahaidib MS. Androctonus crassicauda (Olivier), a dangerous and unduly neglected scorpion, pharmacological and clinical studies. Toxicon. 1994;32(12):1599-618.##Langley RL. A review of venomous animal bites and stings in pregnant patients. Wilderness Environ Med. 2004;15(3):207‐15.##Brown SA, Seifert SA, Rayburn WF. Management of envenomations during pregnancy. Clin Toxicol (Phila). 2013;51(1):3-15.##Ates S, Karahan MA, Altay N, Akelci K, Ikiz N, Guzel B, et al. Approach to scorpion stings in pregnancy: a retrospective case series and literature review. Taiwan J Obstet Gynecol. 2018;57(5):692-5.##Dorce AL, Bellot RG, Dorce VA, Nencioni AL. Effects of prenatal exposure to tityus bahiensis scorpion venom on rat offspring development. Reprod Toxicol. 2009;28(3):365-70.##Ozel A, Demirel N, Gokay O. Ozkan, Androctonus crassicauda zehirinin gebe sı&#231;anlar ve yavruları &#252;zerine etkileri. Kafkas Uni Vet Fak Derg. 2019;25(6):835-40.##Ozkan O, Yagmur EA. Neutralization capacity of monovalant antivenom against existing lethal scorpions in the Turkish Scorpiofauna. Iran J Pharm Res. 2017;16(2):653-60.##Ozkan O, Alcigir ME. A comparative pathomorphological findings between leiurus abdullahbayrami and androctonus crassicauda (Scorpion: Buthidae) envenomation in rabbit animal model. J Arthropod Borne Dis. 2019;13(1):104-15.##Molenberghs G, Geys H, Buyse M. Evaluation of surrogate endpoints in randomized experiments with mixed discrete and continuous outcomes. Stat Med. 2001;20(20):3023-38.##Luna LG. Manual of histologic staining methods of the Armed Forces Institute of Pathology. 1968. 3rd Edition, McGraw-Hill, New York.##Bakir F, Ozkan O, Alcigir M, Vural S. Effects of androctonus crassicauda scorpion venom on the heart tissue. J Anim Vet Adv. 2012;11:2594-9.##van der Meijden A, Coelho P, Rasko M. Variability in venom volume, flow rate and duration in defensive stings of five scorpion species. Toxicon. 2015;100:60-6.##Martin-Eauclaire MF, Adi-Bessalem S, Hammoudi-Triki DF, Bougis PE. Serotherapy against voltage-gated sodium channel-targeting α Toxins fro. Laraba-Djebarim Androctonus scorpion venom. Toxins (Basel). 2019;11(2):63.##Ismail M, Ellison AC, Tilimsany AK. Teratogenicity in the rat of the venom from the scorpion Androctonus amoreuxi (Aud. &amp; Sav.). Toxicon. 1983;21(2):177-89.##Cruttenden K, Nencioni ALA, Bernardi MM, Dorce VAC. Reproductive toxic effects of Tityus serrulatus scorpion venom in rats. Reprod Toxicol. 2008;25(4):497-503.##Dorce AL, Dorce VA, Nencioni AL. Effects of in utero exposure to Tityus bahiensis scorpion venom in adult rats. Neurotoxicol Teratol. 2010;32(2):187-92.##Schneider ML, Roughton EC, Koehler AJ, Lubach GR. Growth and development following prenatal stress exposure in primates: an examination of ontogenetic vulnerability. Child Dev. 1999;70(2):263-74.##Alcigir ME, Ozkan O. The Evaluation of androctonus crassicauda antivenom against the effects of aegaeobuthus nigrocinctus scorpion venom on autophagy, apoptosis and necroptosis. J Arthropod Borne Dis. 2022;16(4):288-300.##Newman LM, Johnson EM. Abnormal lung function induced by prenatal insult. In: Johnson EM, Kochhar DM, editors. Teratogenesis and Reproductive Toxicology. New York: Springer; 1983;237–58.##Fukuhara YDM, Reis ML, Dellalibera-Joviliano R, Cunha FQC, Donadi EA. Increased plasma levels of IL-1β, IL-6, IL-8, IL-10 and TNF-α in patients moderately or severely envenomed by Tityus serrulatus scorpion sting. Toxicon. 2003;41(1):49-55.##Girard S, Tremblay L, Lepage M, S&#233;bire G. IL-1 receptor antagonist protects against placental and neurodevelopmental defects induced by maternal inflammation. J Immunol. 2010;184(7):3997-4005.##Dousset E, Carrega L, Steinberg JG, Clot-Faybesse O, Jouirou B, Sauze N, et al. Evidence that free radical generation occurs during scorpion envenomation. Comparative biochemistry and physiology. Comp Biochem Physiol C Toxicol Pharmacol. 2005;140(2):221-6.##Al&#231;ığır ME, Ozkan O. The autophagy creates balance mechanism between apoptosis and necroptosis: A scorpion (Mesobuthus nigrocinctus) envenomation-anti-venom administration modelling in mice. MDPI Proceedings. 2018;2:2523.##Demirel MA, Alcigir ME, Ozkan O, Turkmen MB. The effects of antivenom administrations on the brain tissue of experimentally envenomed pregnant rats and their pups with Androctonus crassicauda scorpion venom during organogenesis period.  Toxicon. 2021;200:13-8.##</REF>
        </REFRENCE>
    </REFRENCES>
</ARTICLE>

    </ARTICLES>
  </JOURNAL>
</XML>
